Insuman® Basal GT

Insuman Basal GT 100 I.U./ml

Nọmba ndebanye: P Nke 011994/01 nke July 26, 2004

Ngwakọta

1 ml nke mwepu na-anọpụ iche maka ntụtụ nwere 100 IU nke insulin mmadụ (100% crystalline insulin protamine).
Ndị pụrụ iche: protamine sulfate, m-cresol, phenol, zinc chloride, sodium dihydrogen phosphate dihydrate, glycerol, sodium hydroxide, hydrochloric acid, mmiri maka injection.

Ngwongwo ogwu:

Ihe ngbanwe

  • hypoglycemia,
  • Mmetụta hypersensitivity na insulin ma ọ bụ nke ọ bụla nke inyeaka ọgwụ ahụ, ewezuga ọnọdụ ebe ọgwụgwọ insulin dị mkpa. N'ọnọdụ ndị dị otú a, ojiji nke Insuman Bazal GT ga-ekwe omume naanị site na nlekọta nlekọta ahụike yana, ọ bụrụ na ọ dị mkpa, yana njikọ na ọgwụ mgbochi nfụkasị.

Kpachara anya na ntuziaka pụrụ iche

Mmeghachi omume nwere ike ịgha ọgwụ mgbochi insulin nke mmadụ nwere insulin sitere na anụmanụ. Site na mmụba dị ukwuu nke onye ọrịa ka insulin sitere na anụmanụ, yana m-cresol, ekwesịrị ịhapụ nnabata nke Insuman Bazal GT n'ụlọ ọgwụ na-eji nnwale intradermal. Ọ bụrụ na mgbe a na - achọpụta insulin na - enyocha insulin mmadụ (mmeghachi omume ozugbo, dị ka Arthus), mgbe ahụ ọ ga - eme ọgwụgwọ ọzọ n'okpuru nlekọta ahụike. N'ime ọnụ ọgụgụ dị ukwuu nke ndị ọrịa nwere insulin na-emetụta insulin nke anụmanụ, ọ siri ike ịgbanwe insulins mmadụ n'ihi mmeghachi omume mgbochi nke insulin mmadụ na insulin nke sitere anụmanụ.
Hypoglycemia nwere ike itolite ma ọ bụrụ na ego insulin agbakọtara karịrị mkpa ọ dị.
Enwere ụfọdụ mgbaama na akara aka nke kwesịrị igosi onye ọrịa ma ọ bụ ndị ọzọ gbasara ogo shuga dị n'ọbara. Ndị a gụnyere: ọsụsọ na mberede, palpitations, ịma jijiji, agụụ, agụụ, ụra, ọgba aghara ụra, ụjọ, ịda mba, mgbakasị ahụ, omume pụrụ iche, nchekasị, paresthesia n'ọnụ na gburugburu ọnụ, pallor, isi ọwụwa, enweghị nhazi nke mmegharị, yana oge dị mkpirikpi. nsogbu akwara ozi (enweghi ike ikwu okwu na anya, ihe mkpọnwụ) na mmetụta pụrụ iche. Site n’ibelata ọkwa shuga, onye ọrịa nwere ike ịkwụsị njide onwe onye na ọbụna ịma. N'ụdị ndị dị otú ahụ, enwere ike ịmịchaa ma ọ bụ iru mmiri nke akpụkpọ ahụ, ihe ọdịdọ nwekwara ike ịpụta.
Ọtụtụ ndị ọrịa, n'ihi usoro nzaghachi adrenergic, nwere ike ịmalite mgbaàmà ndị a, na-egosi mbelata ọbara shuga: ọsụsọ, mmiri anụ ahụ, nchekasị, tachycardia (palpitations), ọbara mgbali elu, ịma jijiji, obi mgbu, obi ọgba aghara.
Ya mere, onye ọrịa ọ bụla na-arịa ọrịa shuga ma na-anata insulin ga-amụta ịmata akara ndị a na-adịghị ahụkebe nke na-egosi ịmalite hypoglycemia. Ndị ọrịa na-enyocha shuga na mmamịrị ọbara mgbe niile o yikarịrị ka ọ ga-ebute hypoglycemia. Uche nke hypoglycemia siri ike nwere ike imebi ikike onye ọrịa ịnya ụgbọ ala ma rụọ akụrụngwa ọ bụla. Onye ọrịa ahụ nwere ike idozi mbelata ogo shuga ọ chọpụtara site n’ị sugarụ shuga ma ọ bụ nri nwere oke carbohydrates. Maka ebumnuche a, onye ọrịa ahụ kwesịrị ịnwe glucose 20 g mgbe niile. Na ọnọdụ siri ike karị nke hypoglycemia, a na-egosipụta ntụtụ glucagon (nke dọkịta ma ọ bụ ndị ọrụ nọọsụ nwere ike ịme ya). Mgbe mmezi zuru oke, onye ọrịa ahụ kwesịrị iri nri. Ọ bụrụ na enweghị ike iwepụ hypoglycemia ozugbo, mgbe ahụ, ekwesịrị ịkpọ dọkịta ozugbo.Ọ dị mkpa ịgwa dọkịta ozugbo maka mmepe nke hypoglycemia ka o wee mee mkpebi banyere mkpa ịhazigharị ọgwụ insulin.
N'ọnọdụ ụfọdụ, mgbaàmà hypoglycemia nwere ike ịdị nro ma ọ bụ anọghị ya. Ọnọdụ ndị dị otú ahụ na-eme na ndị ọrịa meworo agadi, ọnụnọ ọnya akwara (neuropathy), na ọrịa uche na-ezukọ, na-eji usoro ọgwụgwọ na-a conụ ọgwụ ndị ọzọ (lee “njikọta na ọgwụ ndị ọzọ”), na-enwe ọ̀tụ̀tụ̀ shuga dị n'ọbara shuga, mgbe na-agbanwe insulin.
Ihe ndị na-esote ya ga - ekwe omume ịbelata shuga dị n'ọbara: oke insulin ịba ụba, ntụtụ insulin (na ndị ọrịa mere agadi), ịgbanye ụdị insulin ọzọ, ịpụ nri, vomiting, afọ ọsịsa, mmega ahụ, belata ọnọdụ ndị na - akpata nchekasị, ị drinkingụ mmanya na-egbu egbu, na ọrịa ndị na - ebelata mkpa na insulin (ọrịa imeju ma ọ bụ akụrụ siri ike, ọrụ nke adrenal cortex, pituitary ma ọ bụ thyroid gland), mgbanwe nke ebe ngbanwe (dịka ọmụmaatụ, akpụkpọ nke afọ, ubu ma ọ bụ apata ụkwụ), yana mmekorita ya na ogwu ozo. site na enyemaka nke ọgwụ (lee "Mmekọrịta na ọgwụ ndị ọzọ")
Ihe ize ndụ nke ịmalite hypoglycemia dị elu na mmalite ọgwụgwọ insulin, mgbe ị na-agbanye na nhazi insulin ọzọ, na ndị ọrịa nwere ọkwa shuga dị ala.
Otu ihe egwu pụrụ iche nwere ndị ọrịa nwere ọrịa hypoglycemia na mbelata akụkụ ụkwara ume ma ọ bụ arịa ụbụrụ (yana oke ọbara ma ọ bụ ụbụrụ), yana ndị ọrịa nwere ọrịa retinopathy.
Ọ bụrụ na ịhapụ iso nri, ị inụ insulin insulin, ịba ụba insulin n'ihi ọrịa na-efe efe ma ọ bụ ọrịa ndị ọzọ, na mbelata ọrụ mmega ahụ nwere ike ibute mmụba shuga ọbara (hyperglycemia), ikekwe site na mmụba na ọkwa nke ketone ahụ n'ime ọbara (ketoacidosis). Ketoacidosis nwere ike itolite n’ime awa ole na ole ma ọ bụ ụbọchị ole na ole. Na mgbaàmà mbụ nke metabolic acidosis (akpịrị ịkpọ nkụ, urination ugboro ugboro, ụkọ nri, ike ọgwụgwụ, anụ ahụ akpọnwụ, iku ume na ngwa ngwa, oke acetone na glucose na mmamịrị), itinye ọgwụ ngwa ngwa dị mkpa.
Mgbe ị na-agbanwe dọkịta (dịka ọmụmaatụ, n’oge ụlọ ọgwụ n’ihi ihe ọghọm, ọrịa n’oge ezumike), onye ọrịa ahụ ga-agwa dọkịta na o nwere ọrịa shuga.

Ime na lactation

Ọgwụgwọ Insuman Bazal GT kwesịrị ịga n’ihu n’oge afọ ime. N'oge afọ ime, ọkachasị mgbe ọnwa nke mbụ gasịrị, ekwesịrị ịbawanye ụba na insulin chọrọ. Agbanyeghị, ozugbo a mụsịrị nwa, mkpa ịba insulin na-agbadata, nke gụnyere nnukwu ihe ize ndụ nke hypoglycemia. Ọ bụrụ na ị dị ime ma ọ bụ na-eme atụmatụ ịtụrụ ime, jide n’aka gwa dọkịta gị.
N'oge ị na-enye nwa ara, enweghị mgbochi ọ bụla na usoro insulin. Agbanyeghị, enwere ike ịchọ dose na mmegharị nri.

Nhazi ọkwa nosological (ICD-10)

Nkwụsịtụ maka nchịkwa okpuru ala1 ml
Nnukwu insulin (protine insulin nke na-eme 100%)3,571 mg (100 IU)
ndị mbụ: sulfate protamine - 0.318, metacresol (m-cresol) - 1.5 mg, phenol - 0.6 mg, zinc chloride - 0.047 mg, sodium dihydrogen phosphate dihydrate - 2.1 mg, glycerol (85%) - 18.824 mg, sodium hydroxide (eji emezi pH) - 0,576 mg, hydrochloric acid nke etinyere (iji dozie pH) - 0.246 mg, mmiri maka ntụtụ - ihe ruru 1 ml

Insulin Insuman Bazal GT - ntuziaka maka ojiji

Treatmentgwọ ọrịa shuga na-achọkarị ọgwụ eji nwere insulin. Ndị a gụnyere Insuman Bazal GT. Ọ bara uru ịchọpụta ihe akụrụngwa ya na njirimara ya nke mere na usoro ọgwụgwọ ekpughere dị mma ma dịkwa mma.

Onye mepụtara ọgwụ a bụ France.Ngwá ọrụ dịịrị otu hypoglycemic. Emere ya na nbido insulin nke mmadu. Na erere ahia di n ’udiri mmachi. Ogologo oge ekpughere ya na ihe na-arụ ọrụ bụ ọkara.

Na mgbakwunye na akụrụngwa na-arụ ọrụ, a na-etinye ihe ndị ọzọ na ọgwụ a na-enyere aka ịbawanye arụmọrụ ya.

Ndị a gụnyere:

  • mmiri
  • zinc chloride
  • phenol
  • protamine sulfate,
  • sodium hydroxide
  • glycerol
  • metacresol
  • mmiri ọgwụ na-egbu mmiri,
  • hydrochloric acid.

Vidiyo (pịa igwu egwu).

Nkwụsị ahụ kwesịrị ịbụ ụdị. Agba ya na-achakarị ọcha ma ọ bụ na-acha ọcha. Jiri ya n'ụzọ aghụghọ.

Can nwere ike ịhọrọ otu ụdị dabara adaba nke achọtara na ire:

  1. Cartugges 3 ml (ngwugwu 5 pcs.).
  2. A na-edebe katọn dị na pensụl. Olu ha dịkwa 3 ml. Nkeji sirinji nke ọ bụla. N'ime ngwugwu ahụ 5 pcs.
  3. 5 ml vials. A na-eji iko na-enweghị iko mee ha. Na mkpokọta, enwere karama 5 dị otu otu.

Jiri ọgwụ ahụ naanị dị ka onye ọkachamara gwara gị, na-eburu n'uche njirimara na adịghị ike. Nwere ike ịmụ naanị ihe gbasara njiri ọgwụ a. Maka ngwa kwesịrị ekwesị, achọrọ ihe ọmụma pụrụ iche.

Vidiyo (pịa igwu egwu).

Mmetụta ọgwụ ọ bụla bụ n'ihi ihe ndị nọ n'ọrụ na-etinye na ihe mejupụtara ya. Na Insuman Bazal, ihe na-arụ ọrụ bụ insulin, nke a na-enweta site na usoro. Mmetụta ya yiri nke insulin nkịtị na-emepụta n'ime ahụ mmadụ.

Mmetụta ya na ahụ dị ka ndị a:

  • mbelata shuga
  • mkpalite mmetụta anabolic,
  • na-ebelata catabolism,
  • na-eme ka nkesa glucose dị na ngwa rụọ ọrụ site n'ime ka ọ nwee ike na - emegharị ihe na - emegharị ya,
  • ụba glycogen emeputa,
  • mmepu nke glycogenolysis na usoro glyconeogenesis,
  • mbelata na ọnụego lipolysis,
  • mụbara lipogenesis n’imeju,
  • ngwangwa usoro nke protein protein,
  • ahụ na - akpali potassium na ahụ.

Otu njiri mara nke ihe na-eme aru oru ma obu ihe nlere ogwu a bu oge o ji aru oru. N'otu oge ahụ, nsonaazụ ya anaghị esite ozugbo, kama ọ na - amalite nke nta nke nta. A na-ahụpụta nsonaazụ izizi otu elele mgbe ịgba ọgwụ ịgba. Ọgwụ kachasị dị irè na-emetụta ahụ mgbe awa 3-4 gachara. Mmetụta nke ụdị insulin a nwere ike ịdịru awa 20.

Nnabata ọgwụ a sitere na anụ ahụ dị n'okpuru ala. N'ebe ahụ, insulin na-ejikọtara ndị na-anabata ya kpọmkwem, n'ihi nke a na-ekesa ya na akwara anụ ahụ. Kpochapụ ihe a na-eme site na akụrụ, yabụ ọnọdụ ha na-emetụta ọsọ nke usoro a.

Iji ọgwụ ọ bụla kwesịrị ịdị nchebe. Nke a bụ eziokwu bụ eziokwu maka ọgwụ ndị na-eme ka ihe dị mkpa jupụta n'ihe ụfọdụ, nke gụnyere ọ̀tụ̀tụ̀ shuga dị n'ọbara.

Iji mee ka ọgwụgwọ ahụ ghara imerụ onye ọrịa ahụ, ịkwesịrị ịgbaso ntuziaka maka ọgwụ ahụ ma jiri ya naanị ma ọ bụrụ nchoputa dabara adaba.

A na-eji insuman Bazal na-agwọ ọrịa shuga. Edere ya na ọnọdụ ebe onye ọrịa chọrọ iji insulin mee ihe. Mgbe ụfọdụ a na-eji ọgwụ ahụ eme ihe na ụzọ ndị ọzọ, mana a na-anakwere monotherapy.

Akụkụ kachasị mkpa nke iji ọgwụ eme ihe bụ ịtụle contraindications. Maka ha, ọgwụ ahọpụtara nwere ike ime ka ọdịmma onye ọrịa ka njọ, yabụ dọkịta ga-ebu ụzọ mụọ ihe ahụ mere ma mee nyocha ndị dị mkpa iji hụ na enweghị mmachi.

A na - akpọ ụfọdụ n'ime ihe ndị contraindications nke insuman ga - arụ ọrụ:

  • ndidi insulin,
  • anagideghi ihe inyeaka nke ogwu a.

N'ime mmachi gosipụtara atụmatụ ndị dị ka:

  • ime
  • inye ara
  • imeju imeju
  • pathology na arụ ọrụ akụrụ,
  • agadi na ụmụaka nke onye ọrịa.

Ọnọdụ ndị a abụghị ọgwụ siri ike, mana ndị dọkịta kwesịrị ịkpachara anya mgbe ha na-ede ọgwụ. N ’oge a, usoro ndị a bụ nke usoro nyocha nke ọkwa glucose na nhazi nke usoro onunu ogwu. Nke a na-ebelata ihe egwu nke nsonaazụ achọghị.

N'ịmụta njirimara nke omume nke ọgwụ ọ bụla, ọ dị mkpa ịchọpụta otu o si emetụta ụmụ nwanyị n'oge ime na lactation.

Zụ nwatakịrị na-akpatakarị mmụba shuga dị n'ọbara nne nke a na-atụ anya ya, bụ́ ihe dị mkpa banyere ịdị otú ihe ndị a si egosi. Ọ dị ezigbo mkpa ịghọta ụdị ọgwụ dị mma na ọnọdụ a.

Enweghi data ziri ezi na nsonaazụ insuman n'ahụ nwanyị dị ime na nwa ebu n’afọ enwetabeghị. Dabere na ozi izugbe banyere ọgwụ nwere insulin, anyị nwere ike ikwu na ihe a anaghị abanye na Plasenta, yabụ ọ nweghị ike ibute ọgba aghara na mmepe nwata.

Onye ọrịa ahụ n’onwe ya kwesịrị ị rite uru na insulin. Ka o sina dị, dibịa na-aga ga-elele njirimara niile nke foto ụlọ ọgwụ ma jiri nlezianya nyochaa oke glucose. N'oge afọ ime, shuga nwere ike ịgbanwe nke ukwuu dabere na oge, yabụ ịkwesịrị nyochaa ha, na-edozi akụkụ insulin.

Site na inye nri nwata ahụ, a na-ahapụkwa iji Insuman Bazal. Ihe mejupụtara ya bụ ngwakọta protein, yabụ mgbe ọ bịakwutere nwa yana mmiri ara, a gaghị ahụta mmerụ ahụ. A na - ekewa ihe ahụ n’ime digestive traktị nke nwa ahụ ka amino acid ma banye. Ma ndi nne gosiputara nri n’oge.

Na ọgwụgwọ ọrịa shuga na kwụsịtụ. Insuman Bazal aghaghi iburu n'uche mgbanwe nile na - eme n’ahụ onye ọrịa. Ha adịchaghị mma. Dịka ekwuru na nyocha ndị ọrịa, ọgwụ a nwere ike ibute ọtụtụ nsonaazụ, ụkpụrụ nke ikpochapu nke dabere na ụdị ha, ike ha na njirimara ndị ọzọ. Ọ bụrụ na ha mee, enwere ike idozi usoro onunu ogwu, usoro ọgwụgwọ Symptomatic, yana dochie ọgwụ a na analogues ya.

Ihe omumu a bu otu n’ime ihe kariri mgbe eji insulin. Ọ na - etolite ma ọ bụrụ na ahọpụtara ọgwụ nke ezighi ezi ma ọ bụ na ọnụnọ nke hypersensitivity na onye ọrịa. N'ihi ya, a na - arụ ọrụ insulin karịa ka ọ dị mkpa, nke a ga - eji belata ogo shuga. Nsonaazụ dị otú ahụ dị oke egwu, ebe ọ bụ na nnukwu ọrịa hypoglycemia nwere ike igbu egbu.

A na - eji amata hypoglycemia site na:

  • ịta ahụhụ,
  • anya ntughari
  • agụụ
  • ogwe
  • ọnwụ nke mmụọ
  • ịma jijiji
  • tachycardia ma ọ bụ arrhythmia,
  • mgbanwe ọbara mgbali, wdg.

Nwere ike iwepu hypoglycemia dị nro site na nri nke nwere carbohydrates ngwa ngwa. Ha na-abawanye ọkwa glucose na nkịtị ma mezie ọnọdụ ahụ. N'okwu siri ike nke ihe a, a chọrọ enyemaka ahụike.

Usoro ụfọdụ ji alụso ọrịa ọgụ nwere ike ịgwọ ọgwụ a yana ọrịa ara. A, iji gbochie ụdị ikpe a, a na-ebu ụzọ nnwale maka enweghị ntinye aka na ihe mejupụtara.

Ma mgbe ụfọdụ, a na-enye ọgwụ ị withoutụ ọgwụ ahụ na-enweghị ụdị ule ahụ, nke nwere ike ịkpasu ihe omume ndị a

  • mmeghachi omume anụ ahụ (edema, ọbara ọbara, ihe ngbu, itching),
  • bronchospasm
  • wedata ọbara mgbali elu,
  • angioedema,
  • nsogbu anaphylactic.

Offọdụ n'ime mmeghachi omume ndị a dị n'elu anaghị atụle ihe egwu. N'ọnọdụ ndị ọzọ, achọrọ ịkagbu Insuman ozugbo, n'ihi na onye ọrịa ahụ nwere ike ịnwụ n'ihi ya.

Usoro ọgwụgwọ insulin nwere ike ime ka nchịkwa metabolic mụbara, n'ihi nke onye ọrịa ahụ nwere ike ịmalite edema. Ọzọkwa, ngwá ọrụ a na-eduga na oge igbu sodium n'ahụ ahụ ụfọdụ ndị ọrịa.

N’akụkụ akụkụ ahụ na-ahụ anya, anụ ahụ na akpụkpọ anụ

Ọrịa nlere anya na-aputa ihe na-agbanwe n'ihi na mgbanwe mberede na ọgụgụ gul. Ozugbo enwere njikọta glycemic, mmebi iwu ndị a na-agafe.

Otu n'ime nsogbu ndị anya na - ahụkarị gụnyere:

  • mụbara ọrịa ịba ọcha n'anya,
  • nsogbu ndị na-ahụ anya oge nwa,
  • nwa oge.

N'akụkụ a, ọ dị ezigbo mkpa iji gbochie mgbanwe na ọkwa shuga.

Mmetụta dị ukwuu megide anụ ahụ dị n'okpuru ala bụ lipodystrophy. Ọ bụ n'ihi ntụtụ ahụ n'otu mpaghara ahụ, nke na-akpata ọgba aghara na ntinye nke ihe na-arụ ọrụ.

Iji gbochie ihe ịtụnanya a, a na-atụ aro ka ịgbakwunye mpaghara nke nchịkwa ọgwụ n'ime mpaghara nke kwere omume maka ebumnuche ndị a.

Ihe na egosiputa akpukpo aru bu ihe n’enweghi ike nke insulin na aru. Mgbe oge ụfọdụ gasịrị, a na-ewepụ ha n'enweghị ọgwụgwọ, Otú ọ dị, dibịa na-aga ahụ kwesịrị ịmara banyere ha.

Ndị a gụnyere:

  • mgbu
  • acha ọbara ọbara
  • etughari edema,
  • itching
  • urticaria
  • mbufụt

Ihe mmeghachi omume ndị a niile na-apụta naanị ma ọ bụ n'akụkụ ebe injection.

A ga-eri ọgwụ ọgwụ Insuman na subcutaneously. Ekwesịrị ịbanye na ya n'apata ụkwụ, ubu ma ọ bụ mgbidi akụkụ nke ime. Iji zere mmepe nke lipodystrophy, ekwesighi injections n'otu ebe ahụ, ekwesịrị ịhọrọ ebe ndị ọzọ. Oge kachasị mma maka ịgba ntụtụ bụ oge tupu nri (ihe dị ka otu awa ma ọ bụ obere obere). Yabụ ọ ga - ekwe omume ịnweta oke arụmọrụ kachasị.

Na nkezi, usoro ịdebere mbụ bụ nkeji 8-24 n'otu oge. Na-esote, enwere ike idozi dose a elu ma ọ bụ ala. Oke kacha anabata maka ijere ya ozi bụ nkeji iri anọ.

Nhọrọ nke dose na-emetụta ụdị ngosipụta ahụ dị ka uche nke anụ ahụ na-arụ ọrụ nke ọgwụ ahụ. Ọ bụrụ na enwere mmetụta siri ike, ahụ na-emeghachi insulin ngwa ngwa, yabụ ndị ọrịa dị otú ahụ chọrọ obere akụkụ, ma ọ bụrụ na hypoglycemia nwere ike ịmalite. Maka ndị ọrịa nwere ezi mmụọ maka ọgwụgwọ na-arụpụta ihe, ekwesịrị ịbawanye usoro onunu ogwu.

Nkuzi vidiyo na iji sirinji:

Nyefee onye ọrịa na ọgwụ ọzọ kwesịrị ịnọ n'okpuru nlekọta ahụike. A na-eme nke a iji gbochie mmepe nke nsonaazụ na-adịghị mma n'ihi contraindications ma ọ bụ mmetụta ndị ọzọ. Ọ na-emekwa na onye ọrịa ahụ enweghị obi ụtọ maka ọnụ ahịa Bazal.

Dọkịta kwesịrị ị doseụ ọgwụ ọgwụ ọhụụ gwọọ nke ọma ka ọ ghara ibute ọgbaghara siri ike na profaịlụ glycemic - nke a dị njọ site na nsonaazụ. Ọ dịkwa ezigbo mkpa ịlele ọkwa glucose ọbara nke onye ọrịa iji gbanwee usoro ọgwụ a n'oge ma ọ bụ ịghọta na o rughị mma maka ọgwụgwọ.

Ka ịgbanwee usoro onunu ogwu, dibia kwesiri inyocha ogo ya. Ọ bụrụ na ọgwụ nke ọgwụ edepụtara edepụtara edepụtaghị nsonaazụ, ịchọrọ ịchọpụta ihe kpatara nke a ji eme. Naanị mgbe nke a gasịrị, enwere ike ịbawanye dose ahụ, na-achịkwa usoro ọzọ.

Mgbe ụfọdụ mmeghachi omume na ọgwụ ahụ nwere ike ịnọ ebe ahụ n'ihi njirimara nke ahụ, na hyperreactivity na-etolite n'ihi ọnụnọ nke contraindications. Naanị ọkachamara nwere ike ịghọta nke a.

Onwere otutu ndi oria di iche-iche daburu n’adiri ichoro ilezi anya.

  1. Womenmụ nwanyị dị ime na ịctụ nwa. Banyere ha, ọ dị mkpa iji nlezianya nyochaa ndị na-egosi glucose ma gbanwee akụkụ nke ọgwụ dabere na nsonaazụ ndị a.
  2. Ndị ọrịa nwere nsogbu gbasara akụrụngwa yana ọrụ ịba ọcha n'anya. Ọgwụ ndị a na-emetụta akụkụ ahụ ndị a. Ya mere, na ọnụnọ ọrịa na mpaghara a, onye ọrịa chọrọ ọgwụ belata.
  3. Ndị okenye na-arịa ọrịa. Site n'ọgbọ dị onye ọrịa ihe karịrị afọ 65, ọ ga-ekwe omume ịchọpụta ọrịa na-arụ ọrụ nke akụkụ dị iche iche. Mgbanwe afọ-emetụta nwere ike imetụta imeju na akụrụ.Nke a pụtara na maka ndị dị otú ahụ, a ga-ahọrọ usoro ọgwụgwọ ahụ nke ọma. Ọ bụrụ na enweghi mmebi na akụkụ ahụ ndị a, mgbe ahụ ị nwere ike ịmalite site na akụkụ mbụ, mana ịkwesịrị ịme nyocha oge ụfọdụ. Ọ bụrụ na akụrụ ma ọ bụ imeju akwara etolite, belata belata insulin riri.

Tupu ịzụta Insuman Bazal, ịkwesịrị ijide n'aka na ọ ga-aba uru.

Mmụba na-akwadoghị na dose nwere ike ime ka ịdoụ ọgwụ ọdoụdoụ gabigara ókè. Ọtụtụ mgbe, nke a na - eduga na ọnọdụ hypoglycemic, ogo nke nwere ike ịdị iche iche. N'ọnọdụ ụfọdụ, na enweghị nlekọta ahụike, onye ọrịa ahụ nwere ike ịnwụ. Site n'ụdị hypoglycemia na-esighi ike, ị nwere ike ịkwụsị ọgụ site n'enyemaka nke nri bara ụba na carbohydrates (shuga, Grafica, wdg).

Insuman Bazal GT: Ntụziaka maka ojiji na nyocha

Aha Latin: Insuman Basal GT

Koodu ATX: A10AC01

Ngwakọta ọrụ: insulin mmadụ, isophane (Insulin mmadụ, isophane)

Onye na-emepụta: Sanofi-Aventis Deutschland, GmbH (Sanofi-Aventis Deutschland, GmbH) (Germany)

Na-emelite nkọwa na foto: 11.29.2018

Insuman Bazal GT - insulin nke mmadụ nke oge ọrụ.

Sdị usoro onunu ogwu - nkwusioru maka ochichi subcutaneous (s / c): na-agbasasị ihe dị mfe, ihe fọrọ nke nta ka ọ bụrụ ọcha ma ọ bụ na-acha ọcha (3 ml nke ọ bụla na katrized iko na-enweghị agba, 5 katọn dị na paịlị, 1 mkpọ na kaadiboodu, 3 ml na katọn nke iko na-enweghị agba e tinyere na pensụl sịsaịSStar nke nchekwa ya, na ngwugwu kaadiboodu nke pensụl 5, 5 ml na karama iko na-enweghị agba, na bọọdụ mkpọchi karama 5, mkpọ nke ọ bụla nwekwara ntuziaka maka iji insuman Bazal GT).

Ngwakọta nke 1 ml nke nkwusioru:

  • ihe na - arụ ọrụ: insulin-isophan (injin ọrịa mmadụ) - 100 IU (International Units), nke kwekọrọ na 3,571 mg,
  • ihe inyeaka: glycerol 85%, phenol, metacresol (m-cresol), sodium dihydrogen phosphate dihydrate, zinc chloride, sulfate protamine, mmiri maka injection, yana hydrochloric acid na sodium hydroxide (iji dozie pH).

A na - enweta insulin Bazal GT - insulin-isophan site na inyocha mkpụrụ ndụ ihe nketa site na iji ọgwụ co co K12 135 pINT90d, n'ụdị ya na insulin mmadụ.

Ọgwụ na-ebelata glucose ọbara, na-ebelata uto catabolic ma na-akwalite mmepe nke anabolic. Ọ na - eme ka ebulata glucose na potassium banye n'ụba, na - eme ka njikọ nke glycogen nwee umeji na akwara, na - egbochi gluconeogenesis na glycogenolysis, na - eme ka amino acid na - abanye na sel, njikọ protein na iji pyruvate. Isulin insulin na-egbochi lipolysis, na-abawanye lipogenesis n’imeju na anụ ahụ adipose.

Mmetụta hypoglycemic na-amalite n'ime elekere 1, ruru oke mgbe awa 3-4 gachara, na-adịgide ruo awa iri na otu ruo awa iri na abụọ.

Ọkara ọkara nke insulin plasma na ndị ọrụ afọ ofufo nwere ahụike dị ihe dị ka nkeji isii na isii, n'ime ndị ọrịa nwere ọdịda akụrụngwa nke ihe ngosi a na-abawanye.

Pharmlọ ọgwụ ọgwụ nke insulin anaghị egosipụta mmetụta metabolic ya.

A na-eji insuman Bazal GT mee ihe maka ọrịa shuga mellitus chọrọ ọgwụgwọ insulin.

  • hypoglycemia,
  • hypersensitivity na akụrụngwa inyeaka nke ọgwụ ma ọ bụ insulin, ewezuga mgbe ọgwụgwọ insulin dị mkpa.

N'okwu ndị a, a ga-eji ịkpachara anya Insuman Bazal GT (ọ dị mkpa ịhazigharị ọnọdụ nke onye ọrịa):

  • gbasara akwara
  • imeju imeju
  • oria
  • ike stenosis nke akwara ọbara na akwara,
  • inozọ ọrịa protinerative, ọkachasị ndị ọrịa a na-enweteghị ọgwụgwọ na photocoagulation (ọgwụgwọ laser),
  • nká.

Omume ọgwụ

Insuman Bazal GT nwere insulin yiri nke ahuru na insulin mmadu ma nweta site na inyocha ihe omumu site na iji K12 strain E. Coli.

- belata glucose ọbara ma kwalite mmetụta anabolic, ma belata uto catabolic,

- na - akwalite mbufe nke glucose na sel, yana ịkpụkọta glycogen na akwara na imeju na - eme ka ojiji nke pyruvate rụọ. Ọ na-egbochi glycogenolysis na glyconeogenesis,

- na-akwalite lipogenesis na imeju na anụ ahụ na-adịrị adị ma na-egbochi lipolysis,

- na - akpali ike amino asịd site na mkpụrụ ndụ ma na - eme ka protein nwee ike,

- na - akwalite oriri nke potassium site na sel.

Insuman Bazal GT (nkwụchi nke isofan-insulin) bụ insulin nwere mmụba nwayọ na ogologo. Mmetụta hypoglycemic dị n'ime elekere 1, wee rute ihe kachasị n'ime awa 3-4 mgbe nchịkwa ọgwụ subcutaneous. Mmetụta ahụ dịgidere ruo 11-20 awa.

Mlọ ọgwụ

Ọkara ọkara nke insul insulin na-achịkwa ahụike dị ihe dịka nkeji isii na isii. Na nnukwu nsogbu gbasara akụrụ, ọ dị ogologo. Okwesiri iburu n'uche na ọgwụ ọgwụ nke insulin anaghị egosipụta mmetụta metabolic ya.

Nsonaazụ Nchekwa Ọsịsịsịsịfọ

Emere ihe omimi banyere ihe ojoo oke mgbe emere ochichi oke. O nweghi ihe ojoo choputara. Ihe omumu banyere ogwu nke aru nke ihe ochichi nke subcutaneous nke ogwu ahu rue oke bekee na nkita kpughere mmeghachi omume hypoglycemic.

Ime na lactation

Onweghi ihe omumu nke ulo ogwu banyere ojiji insulin n’aru mmadu n’oge di ime. Insulin anaghị agafe ihe mgbochi placental. Mgbe ị na-edenye ndị inyom dị ime ọgwụ ahụ, ha kwesịrị ịkpachara anya.

N'ihe banyere ndị ọrịa na-arịa preexisting ma ọ bụ gellational diabetes mellitus, ọ dị mkpa ịnwe ọnụego metabolic kwesịrị ekwesị n'oge afọ ime. Mkpa insulin n'oge ọnwa atọ nke mbụ nke afọ ime nwere ike belata, mana na nke abụọ na nke atọ ọ na - abawanye. Ozugbo amụrụ nwa, ọgwụ insulin na-agbadata ngwa ngwa (ohere dị ukwuu nke hypoglycemia). Ọ dị mkpa iji nlezianya nyochaa ọkwa nke glucose ọbara.

N'oge ị na-enye nwa ara, enweghị mgbochi ọ bụla na usoro insulin. Agbanyeghị, enwere ike ịchọ ọgwụ insulin na ịmegharị ihe nri.

Usoro onunu ogwu na nhazi

Nhọrọ nke ọkwa glucose ọbara dị mma, nkwadebe insulin na usoro ya maka onye ọrịa ahụ bụ nke dọkịta na-ebu n’otu n’otu, dabere na nri, ọkwa nke mmega ahụ na etu o si ebi ndụ. A na-ekpebi ogo insulin na-adabere n'ọkwa glucose dị n'ọbara, yana dabere na ọkwa nke mmega ahụ na steeti carbohydrate metabolism. Ọgwụ insulin chọrọ ọzụzụ onwe onye dị mma. Dọkịta ga-enye ndụmọdụ dị mkpa ugboro ole iji chọpụta ọkwa nke glucose dị n'ọbara, yana nye nkwenye kwesịrị ekwesị ma ọ bụrụ na mgbanwe ọ bụla na nri ma ọ bụ usoro ọgwụgwọ insulin.

Usoro onunu ogwu ubochi na oge ochichi

Dịka ọ dị, nkezi insulin kwa ụbọchị na-eme ihe sitere na 0,5 ruo 1.0 ME kwa kilogram nke ahụ onye ọrịa, yana ogo 40-60% nke insulin na-arụ ọrụ mmadụ ogologo oge. A na-enyekarị insuman Bazal GT nri nkeji 24-60 tupu nri.

Nghazi udiri ọgwụ na-esote

Improkwalite njikwa glycemic nwere ike ibute mmụba nke insulin, na-eduga n'ịbelata insulin chọrọ. Na mgbakwunye, enwere ike ịchọ ndozi dose, dịka ọmụmaatụ, mgbe ị na-agbanwe oke ahụ onye ọrịa,

- mgbe ịgbanwe ndụ onye ọrịa (gụnyere nri, ọkwa nke mmega ahụ, wdg),

- n’ọnọdụ ndị ọzọ nwere ike ịbawanyewanye ike ịmalite hypoglycemia ma ọ bụ hyperglycemia (lee ntuziaka pụrụ iche na ịkpachara anya maka ojiji).

Ngwa dị iche iche nke ndị chebere iche

N'ime ndị ọrịa agadi na ndị ọrịa nwere obere mkpo ya na ịba ọcha n'anya, enwere ike belata ọgwụ insulin.

A na-achịkwa Insuman Bazal GT na subcutaneously. Nlekọta ọgwụ nchịkwa nke ọbara!

Ntinye insulin na, yabụ, nsonaazụ glucose nke usoro nchịkwa nwere ike ịdị iche dabere na ebe a na-agba agba (dịka ọmụmaatụ, mpaghara nke mgbidi akụkụ ihu ma e jiri ya tụnyere mpaghara feminin). Site na ntụtụ ọ bụla, ekwesịrị ịgbanwe saịtị ntụtụ ahụ n'otu mpaghara ahụ.

Ekwesịrị ịgbanwe saịtị ntụtụ ahụ oge ọ bụla. Shouldgbanwe mpaghara ntụtụ (dịka ọmụmaatụ, site na afọ ruo na apata ụkwụ) ga-eme naanị mgbe ịgachara dọkịta.

A naghị eji insuman Bazal GT n'ọtụtụ ụdị nfuli insulin (gụnyere ndị etinye n'ime ya).

Ejikọla Insuman Bazal GT na insulin nke itinye uche dị iche (dịka ọmụmaatụ, 40 IU / ml na 100 IU / ml), yana insulin nke sitere anụmanụ ma ọ bụ ọgwụ ndị ọzọ.

Ekwesịrị icheta na itinye uche insulin bụ 100 IU / ml (maka vials 5 ml ma ọ bụ katrized 3 ml), yabụ, ọ dị mkpa iji naanị sirinji plastik ezubere maka ịta insulin n'oge a iji mkpịsị vials, ma ọ bụ mkpịsị opipe nke OptiPen Pro1 n'ihe banyere cartridges. Ọkpụkpụ plastik ekwesịghị ịnwe ọgwụ ọ bụla ọzọ ma ọ bụ nha ya.

Tupu usoro insulin nke mbụ na vial ahụ, wepu okpu plastik (ọnụnọ nke okpu bụ ihe akaebe nke vial a na-emechighi). Nsonye ahụ kwesịrị ka agwakọta nke ọma ozugbo ịmalite ịtọlite ​​ya, ụfụfụ agaghị etolite. A na-eme nke a nke ọma site na ịbugharị kalama ahụ, jigide ya n'otu nnukwu oghere n'etiti ọbụ aka. Mgbe agwakọtara, nkwusioru kwesịrị inwe otu edo edo na ụcha na-acha ọcha. Enweghị ike iji nkwụchi ahụ ma ọ bụrụ na enwere ụdị ọzọ, i.e. ọ bụrụ na ọ na-agbanwe ma ọ bụ flakes ma ọ bụ lumps guzobere na mmiri mmiri onwe ya, na ala ma ọ bụ mgbidi nke vial. N'ụdị ndị ahụ, ịkwesịrị iji karama ọzọ na-emezu ọnọdụ ndị a dị n'elu, ịkwesịrị ịgwa dọkịta gị.

Tupu ịnakọta insulin na vial ahụ, olu ikuku nke kwekọrọ na insulin nke a chọrọ ka a na-arara ga-abanye na sirinji ma gbanye ya n'ime vial (ọ bụghị n'ime mmiri mmiri). A ga-atụzi vial na sirinji jiri sirinji kpoo ma jiri insulin achọrọ ya. Tupu ntụtụ, wepụ afụ ikuku n'ime sirinji.

A na-ewere otu akpụkpọ ebe a na-agba ntụtụ, na-etinye agịga n'okpuru anụ ahụ, a na-ejikwa insulin nwayọọ nwayọọ. Mgbe agwesịrị, a na-eji nwayọ wepụrụ agịga ahụ ma jiri ajị owu na-agbanye ya ruo ọtụtụ sekọnd. E kwesịrị idekọ ụbọchị nke akpa insulin site na vial ahụ na akara nke vial ahụ.

Mgbe emepechara, ị nwere ike ịchekwa karama ndị ahụ n ’ọnọdụ okpomọkụ na-agaghị akarị +25 Celsius C maka izu anọ n’ebe a na-echebe ọkụ na ikpo ọkụ.

Tupu ị wụnye kadi ahụ (100 IU / ml) na mkpịsị mkpụrụ ogwu OptiPen Pro1, hapụ ya ka ọ kwụrụ 1-2 ruo mgbe ọ dị n'ọnụ ụlọ. Mgbe nke a gasiri, jiri nwayọ gbanye katriiki (ugboro iri) iji nweta nkwụghachi nke otu. Ihe mgbakwasa obula nwere ihe ozo di iche n’ime ato maka ijiko ihe di n’ime ha. Mgbe ịbatasịrị katalọgụ n’ime mkpịsị sirinji, pịchaa mkpịsị sirinji ọtụtụ oge tupu ntụtụ insulin ọ bụla iji nweta nkwụchi otu. Mgbe agwakọtara, nkwusioru kwesịrị inwe otu edo edo na ụcha na-acha ọcha. Enweghị ike iji nkwụchi ahụ ma ọ bụrụ na enwere ụdị ọzọ, i.e. ọ bụrụ na ọ na-agbanwe ma ọ bụ flakes ma ọ bụ lumps guzobere na mmiri mmiri onwe ya, na ala ma ọ bụ mgbidi nke katrij. N'ụdị ndị ahụ, ịkwesịrị iji katriiki ọzọ na-emezu ọnọdụ ndị a dị n'elu, ịkwesịrị ịgwa dọkịta gị. Wepu uzu ikuku ọ bụla na kateeti tupu ntụtụ (lee ntuziaka maka iji OptiPen Pro1 Syringe Pen).

Emebeghi kaadi ihe ahu ighe Insuman Bazal GT na insulins ndi ozo. Enweghi ike imejuputa katrized ụgbọ ala.

N'ihe banyere nbibi nke mkpụrụ sirinji, ị nwere ike tinye mkpụrụ a chọrọ iji si na katalọgụ jiri sirinji ot. Ekwesịrị icheta na itinye uche nke insulin na katriiki bụ 100 IU / ml, yabụ naanị ịchọrọ iji sirinji plastik ezubere maka itinye insulin nke ntinye. Sirinji ahụ ekwesịghị ịnwe ọgwụ ọ bụla ọzọ.

Mgbe itinyechara katriji ahụ, enwere ike iji ya - ® maka> izu anọ. Ọ na-atụ aro ịchekwa ya n'ọnọdụ okpomọkụ nke na-agaghị akarị 25 Celsius C n’ebe a na-echebe ya site n’ọkụ na ọkụ. Mgbe ị na-eji kọọdụ, ekwesịghị ịchekwa mkpụrụ sirinji na friji.

Mgbe ịbụnyechara katriki ọhụrụ, lelee ọrụ ziri ezi nke mkpịsị ọrịrị tupu ị banye ntụtụ ọgwụ mbụ (lee Ntuziaka maka iji sirinji OptiPen Pro1).

Mmetụta akụkụ

Ọrịa hypoglycemia, nke kachasị emetụta ya, nwere ike ịmalite ma ọ bụrụ na insulin insulin na-akwado gafere mkpa ọ dị. Ọ gaghị ekwe omume igosipụta kpọmkwem ọnọdụ nke hypoglycemia, ebe ọ bụ na uru a na nnwale ụlọ ọgwụ yana iji ọgwụ azụmaahịa nwere ike ịdị iche dabere na ọnụ ọgụgụ ndị mmadụ na usoro ọgwụgwọ. Ọnọdụ siri ike nke hypoglycemia, karịsịa ma ọ bụrụ na a na-eme ya ugboro ugboro, nwere ike ibute mmepe nke mgbaàmà akwara, gụnyere coma, cramps. N'ọnọdụ ụfọdụ, ụdị nke a nwere ike ịnwụ.

N'ọtụtụ ndị ọrịa, akara nke hypoglycemic mbibi nke usoro akwara na-ebute ụzọ site na akara nke adrenergic counterregulation. Dịka iwu, ka ịbawanye n'ọkwa nke glucose n'ọbara na-ebelata, ka a na-akpọkwu ya bụ ihe ịtụnanya na njikwa na akara ya.

Mmeghachi omume ndị a na-esote iji ọgwụ ahụ ma hụkwaa ule dị iche iche edepụtara site na klaasị akwara sistemu na nbelata usoro omume: ihe a na-ahụkarị (> 1/100, 1 / 1.000, 1/10000 ,

Dodoụbiga ya ókè

Doụ ọgwụ insulin karịrị akarị nwere ike ibute nnukwu ọrịa hypoglycemia nke ukwuu.

Ọ bụrụ na onye ọrịa maara, mgbe ahụ, ọ kwesịrị ị gluụ glucose ozugbo, oriri nke ngwaahịa nwere carbohydrates na-esote ya (lee ntuziaka na akpachapụ anya maka ojiji). Ọ bụrụ na onye ọrịa nọ n'ọnọdụ amaghị, ọ dị mkpa iwebata glucagon na / m ma ọ bụ s / c ma ọ bụ ihe ndọpụ glucose dị na / n'ime. Ọ bụrụ na ọ dị mkpa, ịmaliteghachi mmiri nke glucose dị n'elu ga-ekwe omume. N’aka umuaka, egoro glucose na-achịzi ka-ahọrọ ya na ogo nwata.

N'ihe banyere hypoglycemia siri ike ma ọ bụ ogologo oge na-esochi ntụtụ glucagon ma ọ bụ dextrose, a na-atụ aro ka emeghachi ya na iji glucose na-erughị ala iji gbochie ịmaliteghachi hypoglycemia. N'ime ụmụaka, ọ dị mkpa iji nlezianya nyochaa ọkwa nke glucose n'ọbara, n'ihe metụtara mmepe nke hyperglycemia siri ike.

N'okpuru ọnọdụ ụfọdụ, a na-atụ aro ka enye ndị ọrịa ụlọ ọgwụ na ngalaba nlekọta ahụ ike maka nlezianya nlezianya na nlebara anya nke usoro ọgwụgwọ ahụ.

Mmekọrịta na ọgwụ ndị ọzọ

Ojiji nke otutu ogwu otu oge nwere ike ime ka ike gwụ ma ọ bụ kwalite mmetụta hypoglycemic nke Insuman Bazal GT. Ya mere, mgbe ị na - eji insulin, ị gaghị a takeụ ọgwụ ọ bụla na - enweghị ikikere dọkịta.

Hypoglycemia nwere ike ime ma ọ bụrụ na ndị ọrịa n'otu oge na insulin na-enweta ọgwụ antidiabetic onral, ndị na-egbochi ACE, na-enupụ isi, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, acetylsalicylic acid na salicylates ndị ọzọ, ọgwụ sulfonamide.

Enwere ike ịhụ mmeghari nke insulin site na nchịkwa nke insulin na corticotropin, glucocorticosteroids, danazole, diazoxide, diuretics, glucagon, isoniazid, estrogens na progestogens (gụnyere ọgwụ mgbochi), ikike nke phenothiazine, somatotropinatine, somatotropinatine, salbutamol, terbutaline), homonụ thyroid, ndị na-egbochi nchebe na ọgwụ antiykosko (dịka ọmụmaatụ, olanzapine na clozapine).

N'ime ndị ọrịa n'otu oge na-a insụ ọgwụ insulin na beta-mgbochi, clonidine na lithium salts, enwere ike ịhụ mmebi na ike nke insulin. Pentamidine nwere ike ibute hypoglycemia nke hyperglycemia sochiri.

Alcoholụ mmanya na-egbu egbu nwere ike ime ka hypoglycemia ma ọ bụ belata ọkwa glucose ọbara dị ala na ọkwa dị oke egwu. Mmanya Na-a Alụ mmanya

insulin belatara. Dọkịta gị ga-ekpebi ị amountsụ mmanya na-egbu egbu. Hohoụbiga mmanya ókè, yana ị ofụbiga nri ókè, nwere ike ịmetụta ọkwa glucose ọbara. Ndị na-egbochi Beta na-egbochi ohere nke hypoglycemia na, ya na ndị ọrụ ọmịiko ndị ọzọ (clonidine, guanethidine, reserpine), nwere ike ịkụda ma ọ bụ kpochapụ ihe mgbaàmà mbụ nke nrụgide adrenergic (ihe mgbaàmà bụ ihe na-ebute hypoglycemia).

Njirimara nke ogwu

Usoro onunu ogwu nke Insuman Bazal GT bu 100 IU / ml. Mgbe nchịkwa n'okpuru anụ ahụ, ọ na-amalite ime nwayọ, na-enweta mmetụta hypoglycemic n'ime otu elekere. Mbelata kachasị na shuga na-etolite awa 3-4 mgbe ọ gbasịrị, mmetụta a na-adịgide ruo awa 11-20. Usoro ihe eji eme ya nwere njiri mara ya:

  • O nwere mmetụta anabolic, na-egbochi usoro catabolic, na-ebelata oke glucose na plasma ọbara.
  • Ọ na - enyere aka ịbufe glucose n'ime sel ma jiri mkpụrụ glycogen mee ya na hepatocytes na akwara, na - egbochi mmeghachi nke glycogenolysis na gluconeogenesis, na - eme ka uru nke ngwaahịa ikpeazụ pụta - pyruvate.
  • Na-ebelata mmeghachi nke biochemical nke lipolysis, mana na-akpali njikọ nke abụba n'ime imeju.
  • Ọ na - eme ka ebu amino acid na - ebuwanye akụrụngwa na protein protein.
  • Ọ na - enyere akafefe ihe ngafe na mkpụrụ ndụ akwara.

Mmetụta ndu niile nke insulin insulin basal gligram obere.

Njirimara ngwa

Ndị ọrịa nwere ọgwụ mgbochi Insuman Bazal GT, maka ndị enweghị ọgwụ ndị ọzọ ha ga-anabata karịa ka ha kwesịrị, ga-aga n'ihu na ọgwụgwọ n'okpuru nlekọta ahụike siri ike ma, ọ bụrụ na ọ dị mkpa, n'otu oge na ọgwụgwọ mgbochi nfụkasị.

Mmeghachi omume mgbochi nke insulin mmadụ na insulin nke sitere anụmanụ nwere ike omume. Site na mmụba dị ukwuu nke onye ọrịa ka insulin sitere na anụmanụ, yana m-cresol, ekwesịrị ịnagide nnabata nke ọgwụ Insuman Bazal GT n'ụlọ ọgwụ ahụ iji nyocha intradermal. Ọ bụrụ na mgbe a na - achọpụta insulin na - enyocha insulin mmadụ (mmeghachi omume ozugbo, dị ka Arthus), mgbe ahụ ọ ga - eme ọgwụgwọ ọzọ n'okpuru nlekọta ahụike. N'ime ọnụ ọgụgụ dị ukwuu nke ndị ọrịa nwere insulin na-emetụta insulin nke anụmanụ, ọ na-esiri ike ịgbanwere insulin nke mmadụ n'ihi mmeghachi omume mgbochi insulin nke insulin mmadụ na insulin nke sitere anụmanụ.

N'ịrụ ọrụ akụrụngwa arụ ọrụ, mkpa insulin nwere ike ibelata n'ihi mgbanwe nke metabolism ya. Nkọwanye njọ na arụ ọrụ akụrụ na ime agadi nwere ike ibute mbelata nke chọrọ insulin.

Na oke mmebi imeju, ịchọrọ insulin nwere ike belata n'ihi ike gluconeogenesis na-agbanwe ma gbanwee insulin metabolism. Site na nchịkwa glucose na-adịghị mma ma ọ bụ nwee ọchịchọ ịmalite usoro hyperglycemic ma ọ bụ hypoglycemic, tupu ịhazigharị usoro ahụ, ịkwesịrị ịtụle otú onye ọrịa ahụ si agbaso usoro ọgwụgwọ ahụ, nyochaa ebe ntụtụ ahụ, usoro ịgba ọgwụ ziri ezi, ma banye n'ime ihe ndị ọzọ dị mkpa.

Ntughari na Insuman Bazal GT

Ekwesịrị ịmefe onye ọrịa na ụdị ọzọ ma ọ bụ ụdị insulin naanị n'okpuru nlekọta ahụike siri ike. Mgbanwe na usoro onunu ogwu, ika (emeputa), udiri (ihe ndi ozo, NPH, teepu, ime ihe, wdg), mbido (anumanu, mmadu, ihe nlere nke insulin) na / ma obu uzo amuma puru imeghari mgbanwe n’ime insulin.

Mkpa ịgbanwe (dịka ọmụmaatụ, iji belata) ọgwụ ahụ nwere ike ịpụta ìhè ozugbo nnyefe. N'aka nke ọzọ, ụdị mkpa ahụ nwere ike ịmalite nke nta nke nta ọtụtụ izu.

Mgbe ịpụsịrị site na insulin anụmanụ na insulin mmadụ, enwere ike ịchọ mbelata usoro ọgwụgwọ, ọkachasị, na ndị ọrịa:

- N’oge gara aga, a ka nwere ọkwa glucose ọbara n’ime ọkwa dị ala nke nwere ọnọdụ ịba ụba hypoglycemia,

- nke choro otutu insulin buru ibu n'ihi onodu ogwu mgbochi. Jiri nlezianya nyochaa metabolism n'oge mbufe site na otu ọgwụ gaa na ọzọ na izu mbụ ka emesịrị nke a ka akwadoro. Ndị ọrịa chọrọ insulin insulin dị ukwuu n'ihi ọnụnọ ọgwụ insulin nwere ike ịchọ nlekọta ahụike n'ụlọ ọgwụ ma ọ bụ ọnọdụ yiri ya.

Hypoglycemia nwere ike itolite ma ọ bụrụ na ego insulin agbakọtara karịrị mkpa ọ dị.

Enwere ụfọdụ mgbaama na akara aka nke kwesịrị igosi onye ọrịa ma ọ bụ ndị ọzọ gbasara oke mbelata ogo glucose ọbara. Ndị a gụnyere: ọsụsọ na mberede, palpitations, ịma jijiji, agụụ, agụụ, ụra, ọgba aghara ụra, ụjọ, ịda mba, mgbakasị ahụ, omume pụrụ iche, nchekasị, paresthesia n'ọnụ na gburugburu ọnụ, pallor, isi ọwụwa, enweghị nhazi nke mmegharị, yana oge dị mkpirikpi. nsogbu akwara ozi (enweghi ike ikwu okwu na anya, ihe mkpọnwụ) na mmetụta pụrụ iche. Site n’ibelata ogo mgbali glucose, onye ọrịa ahụ nwere ike ịkwụsị njide onwe onye na ọbụna ịma. N'ụdị ndị dị otú ahụ, enwere ike ịmịchaa ma ọ bụ iru mmiri nke akpụkpọ ahụ, ihe ọdịdọ nwekwara ike ịpụta.

Ọtụtụ ndị ọrịa, n'ihi usoro nzaghachi adrenergic, nwere ike ịmalite mgbaàmà ndị a, na-egosi mbelata ọkwa glucose ọbara: ọsụsọ, mmiri anụ ahụ, nchekasị, tachycardia (palpitations), ọbara mgbali elu, ịma jijiji, mgbu obi, ọgba aghara obi. Ya mere, onye ọrịa ọ bụla na-arịa ọrịa shuga ma na-anata insulin ga-amụta ịmata akara ndị a na-adịghị ahụkebe nke na-egosi ịmalite hypoglycemia. Ndị ọrịa na-enyocha ọ̀kwa glucose ọbara n’esepụghị aka nwere ike ịmalite ike hypoglycemia. Uche nke hypoglycemia siri ike nwere ike imebi ikike onye ọrịa ịnya ụgbọ ala ma rụọ akụrụngwa ọ bụla. Onye ọrịa ahụ n’onwe ya nwere ike idozi mbelata nke glucose ọ chọpụtara site n’ịta shuga ma ọ bụ nri dị oke carbohydrates. Maka ebumnuche a, onye ọrịa ahụ kwesịrị ịnwe glucose 20 g mgbe niile. Na ọnọdụ siri ike karị nke hypoglycemia, a na-egosipụta ntụtụ glucagon (nke dọkịta ma ọ bụ ndị ọrụ nọọsụ nwere ike ịme ya). Mgbe mmezi zuru oke, onye ọrịa ahụ kwesịrị iri nri. Ọ bụrụ na enweghị ike iwepụ hypoglycemia ozugbo, mgbe ahụ, ekwesịrị ịkpọ dọkịta ozugbo.Ọ dị mkpa ịgwa dọkịta ozugbo maka mmepe nke hypoglycemia ka o wee mee mkpebi banyere mkpa ịhazigharị ọgwụ insulin.

Otu nsogbu pụrụ iche mejupụtara ndị ọrịa nwere ọrịa hypoglycemia na irighiri mkpụkọ nke akwara ọbara ma ọ bụ arịa ụbụrụ (ọbara ọgbụgba ma ọ bụ mgbasa ụbụrụ n'ihi hypoglycemia), yana ndị ọrịa nwere protinerative retinopathy, ọkachasị ma ọ bụrụ na ejighị Photocoagulation (ihe ize ndụ nke ikpu ìsì n'ihi hypoglyce).

Ihe ọghọm nke ịrịa hypoglycemia dị elu na mmalite nke usoro insulin, mgbe ị na-agbanye na nhazi insulin ọzọ, na ndị ọrịa nwere ọ̀tụ̀tụ̀ glucose dị n'ọbara dị ala.

N'ọnọdụ ụfọdụ, mgbaàmà hypoglycemia nwere ike ịdị nro ma ọ bụ anọghị ya. Ọnọdụ ndị a na - eme n'usoro ndị ọrịa ndị a:

- ndị ọrịa tozuru oke ịkwalite nchịkwa glucose,

- ndi ọrịa nke hypoglycemia bidoro nwayọ,

- ndi ọrịa nwere ogologo ọrịa shuga,

- ọnụnọ ọnya nke akwara ozi (neuropathy),

- ya na oria di nkpa,

- ya na ọgwụ ndi ozo na - achikota ya (lee

Mmekọrịta na ọgwụ ndị ọzọ)

- mgbe ị na - agbanwe insulin.

N'ọnọdụ ndị dị otú ahụ, hypoglycemia nwere ike inwe ụdị dị njọ (yana enwere ike ịmara onwe ya) tupu onye ọrịa achọpụta na ya amalitela hypoglycemia.

Ihe ndị na-esote ya ga - ekwe omume maka mbelata ọbara mgbali elu: ịdoụ insulin ókè, ịba insulin (na ndị ọrịa agadi), ịgbanye ụdị insulin ọzọ, ịfe nri, ọgbụgbọ, afọ ọsịsa, mmega ahụ, belata ọnọdụ ndị na - akpata nrụgide, ị drinkingụ mmanya na-egbu egbu, na ọrịa ndị na - ebelata mkpa ahụ. na insulin (ọrịa imeju ma ọ bụ akụrụ siri ike, ọrụ nke adrenal cortex, pituitary ma ọ bụ thyroid gland), mgbanwe nke ebe ngbanwe (dịka ọmụmaatụ, akpụkpọ nke afọ, ubu ma ọ bụ apata ụkwụ), yana mmekorita ya na ọgwụ ndị ọzọ. ọgwụ ọjọọ (lee anya na ọgwụ ndị ọzọ).

Ọ bụrụ na ịhapụ iso nri, ị inụ insulin insulin, ịba ụba insulin n'ihi ọrịa na-efe efe ma ọ bụ ọrịa ndị ọzọ, na mbelata ọrụ mmega ahụ nwere ike ibute mmụba shuga ọbara (hyperglycemia), ikekwe site na mmụba na ọkwa nke ketone ahụ n'ime ọbara (ketoacidosis). Ketoacidosis nwere ike itolite n’ime awa ole na ole ma ọ bụ ụbọchị ole na ole. Na mgbaàmà mbụ nke metabolic acidosis (akpịrị ịkpọ nkụ, urination ugboro ugboro, ụkọ nri, ike ọgwụgwụ, anụ ahụ akpọnwụ, iku ume na ngwa ngwa, oke acetone na glucose na mmamịrị), itinye ọgwụ ngwa ngwa dị mkpa.

Mgbe ị na-agbanwe dọkịta (dịka ọmụmaatụ, n’oge ụlọ ọgwụ n’ihi ihe ọghọm, ọrịa., N’oge ezumike), onye ọrịa ahụ ga-agwa dọkịta na o nwere ọrịa shuga.

N'ihe banyere mmepe nke ọrịa concomitant, achọrọ nlebara anya. metabolism. N'ọtụtụ oge, enwere ike ịchọ nnwale mmamịrị maka ketones, ọ na-adịkarị mkpa idozi ọ̀tọ insulin. Mkpa insulin na-abawanye. Abetesdị nke Ọrịa shuga, ndị ọrịa kwesịrị ịga n’ihu na-a carbohydụ carbohydrates oge niile, ọbụlagodi na obere obere, ọbụlagodi ma ha nwere ike iri obere nri ma ọ bụ mee nri n’enweghị nri, ma ọ bụ ọ bụrụ na ha nwere ọgbụgbọ na ihe ndị ọzọ, ha ekwesịghị ịhapụ ịgbanye insulin kpamkpam.

A kọrọ njehie ahụike mgbe a tọhapụrụ ụdị ndị ọzọ nke mwepụta nke Insuman, ma ọ bụ insulin ndị ọzọ, na mberede ka edobere n'ọnọdụ Insuman. A ga-enyocha akara insulin mgbe ọ bụla tupu ntụtụ ọ bụla iji zere njehie ọgwụ na-akpata n'etiti insulin insulin na insulins ndị ọzọ.

Nchikota Insuman na pioglitazone

A kọwo ọrịa nke nkụda obi mgbe ejiri pioglitazone jikọtara ya na insulin, ọkachasị ndị ọrịa nwere ihe ọghọm maka ọdịda obi. Ekwesịrị iburu nke a n'uche mgbe ị na-ede akwụkwọ ngwakọta pioglitazone na Insuman. Mgbe ị na-a aụkọta ọgwụ ndị a, ọ dị mkpa iji nyochaa ndị ọrịa n'ihe gbasara ọdịdị nke ihe ịrịba ama na njiri mara nke nkụda obi, oke ibu na edema.

Ekwesịrị ịkwụsị Pioglitazone ma ọ bụrụ na ọrịa ọ bụla na-akawanye njọ nke nkụda obi.

Mmetụta ikike ịkwọ ụgbọ ala na usoro ọrụ

Ike nke onye ọrịa itinye uche na nzaghachi nwere ike ibelata n'ihi hypoglycemia ma ọ bụ hyperglycemia, ma ọ bụ, dịka ọmụmaatụ, n'ihi nkwarụ anya. Nke a dị ize ndụ n'ọnọdụ ebe ikike ndị dị n'elu dị ezigbo mkpa (dịka ọmụmaatụ, mgbe ị na-anya ụgbọala ma ọ bụ igwe na-arụ ọrụ).

E kwesiri ịdọ ndị ọrịa aka na ntị gbasara mkpa ị ga - akpachapụ anya iji zere mmepe nke hypoglycemia mgbe ha na-anya ụgbọala. Nke a dị ezigbo mkpa maka ndị nwere njiri mara nke hypoglycemia dị nwayọ ma ọ bụ na-anọghị, ma ọ bụ nke nwere hypoglycemia na-agakarị. A ga-ewelite ajụjụ banyere ịdụ aka n'ụgbọala na ịchịkwa usoro ọrụ n'ụdị ọnọdụ ndị a

Mpempe mwepụta

Nkwusioru 100 IU / ml - 5 ml nke ọgwụ ahụ na iko nke nghọta transperency1gb ^ iko. Akpọchie karama ahụ, were okpu alịumịnọn kpuchie ya ma kpuchie ya na mkpuchi okpu. Na karama 5 tinyere ntuziaka ngwa n'ime kaadiboodu. Nkwụsị 100 IU / ml - 3 ml nke ọgwụ na katrij nke iko dị ọcha na nke enweghị agba. A na-adọkpụ katrij ahụ n'otu akụkụ ya na cork ma jiri okpu aluminom wee mie ya, n'aka nke ọzọ - ya na eriri. Na mgbakwunye, a na-etinye bọọlụ ọla atọ na katriiki. Katọn 5 na ntuziaka maka iji ya na igbe kaadi.

Ọnọdụ nchekwa

Chekwaa na nju okpomọkụ nke 2 Celsius - 8 Celsius C n’ebe gbara ọchịchịrị.

Emela ifriizi! Ekwekwala ka ite ahụ bata na friza ma ọ bụ ihe akpọre akpọtụrụ.

Mgbe ejiri ya, chekwaa na okpomọkụ agaghị akarị 25 Celsius C na kaadiboodu (mana ọ bụghị na friji).

Nọ ebe aka ndi umu aka!

Mlọ ọgwụ

A na - enweta insulin Bazal GT - insulin-isophan site na inyocha mkpụrụ ndụ ihe nketa site na iji ọgwụ co co K12 135 pINT90d, n'ụdị ya na insulin mmadụ.

Ọgwụ na-ebelata glucose ọbara, na-ebelata uto catabolic ma na-akwalite mmepe nke anabolic. Ọ na - eme ka ebulata glucose na potassium banye n'ụba, na - eme ka njikọ nke glycogen nwee umeji na akwara, na - egbochi gluconeogenesis na glycogenolysis, na - eme ka amino acid na - abanye na sel, njikọ protein na iji pyruvate. Isulin insulin na-egbochi lipolysis, na-abawanye lipogenesis n’imeju na anụ ahụ adipose.

Mmetụta hypoglycemic na-amalite n'ime elekere 1, ruru oke mgbe awa 3-4 gachara, na-adịgide ruo awa iri na otu ruo awa iri na abụọ.

Insuman Bazal GT, ntuziaka maka ojiji: usoro na usoro onunu ogwu

Dọkịta na-ekpebi usoro usoro insulin (usoro na oge nchịkwa) n’otu n’otu maka onye ọrịa ọ bụla, ma ọ bụrụ na ọ dị mkpa, na-agbanwe ya dabere n’usoro onye ọrịa ahụ si dị, etu o siri arụ ọrụ ya na usoro nri.

Enweghị iwu ọ bụla akọwapụtara maka ịgwọ insulin. Nkezi ubochi ubochi bu 0.5-1 IU / n'arọ, ebe onodu insulin na-aru oru ogologo oge bu 40-60% nke insulin kwa ubochi choro.

Dọkịta na-aga ahụ kwesịrị ịkụziri onye ọrịa banyere ugboro ole ọ ga-ekpebi nnabata nke glucose n'ọbara, ma nye ntuzi aka banyere usoro ọgwụgwọ insulin ọ bụla ma ọ bụrụ na mgbanwe ọ bụla n'ụzọ ndụ ma ọ bụ ụdị nri.

A na-ahụkarị insuman Bazal GT nkeji s / c 45-60 nkeji tupu nri.N'ihu nke ọ bụla, a ga-agbanwe saịtị ịgba ọgwụ ahụ n'otu mpaghara nchịkwa. Ekwesịrị ịgbanwe mpaghara (dịka ọmụmaatụ, site na afọ ruo na apata ụkwụ) naanị mgbe ị nyochachara dọkịta, ebe enwere ike ịgbanwe nnabata nke insulin na, n'ihi ya, mgbanwe na mmetụta ya.

Ekwesighi iji insuman Bazal GT n'ọtụtụ nfuli insulin, gụnyere nfuli mmanụ. Amachibidoro nchịkwa ọgwụ mgbochi ọgwụ oke! Nweghị ike ịgwakọta ya na insulins nke ịta dị iche, analogues insulin, insulin nke sitere anụmanụ na ọgwụ ọ bụla.

Anakwere insuman Bazal GT ka ọ gwakọta na nkwadebe insulin niile nke mmadụ nke Sanofi-Aventis Group mepụtara.

Ntinye insulin na nkwadebe bu 100 IU / ml, ya mere, n'ihe gbasara iji 5 ml vials, ekwesịrị iji sirinji plastik maka diski mee ihe maka itinye ihe dị na pọọsụ 3 ml, pịa bọtịnụ Pịa ma ọ bụ mkpịsị OptiPen Pro1.

Ngwa ngwa tupu ịkpọ, nkwanye ahụ ga-agwakọta nke ọma ma nyochaa ya. Nkwadebe maka nchịkwa kwesịrị ịbụ nke edo edo dị ọcha. Ọ bụrụ na nkwusioru ahụ nwere anya dị iche (ọ ka na-apụta ìhè, lumps ma ọ bụ flakes etolite na mmiri mmiri ma ọ bụ na mgbidi / ala nke vial), ịnweghị ike iji ya.

Ntughari na insuman Bazal GT site na udiri insulin ozo

Mgbe ị na-eji ọgwụ insulin dochie otu ọgwụ, ọ na-adịkarị mkpa idozi usoro onunu ogwu, dịka ọmụmaatụ, iji dochie insulin anụmanụ sitere na mmadụ, na-agbanwe site na insulin mmadụ na nke ọzọ, na-ebufe onye ọrịa site na insulin na -akpata mmadụ na insulin na-arụ ọrụ ogologo oge.

N'ihe banyere iji dochie insulin nke anụmanụ sitere na insulin nke mmadụ, ọ nwere ike ịdị mkpa iji belata ọgwụ insuman Bazal GT, ọkachasị ndị ọrịa enyerela ọrụ na glucose dị ala nke ọma, n'ọbara ya, iwulite inspoglycemia, nke achọrọ insulin dị elu na mbụ n'ihi ọnụnọ ọgwụ mgbochi ya. .

Enwere ike ịchọ Mbelata dose ozugbo ka ị na-ebufe onye ọrịa na ụdị insulin ọzọ. Ọzọkwa, mkpa insulin nwere ike belata nwayọ nwayọ karịa ọtụtụ izu.

N'oge mgbanwe a na insulin Bazal GT nwere ụdị insulin ọzọ na izu izizi nke ọgwụgwọ, ọ dị mkpa iji nlezianya nyochaa ọkwa nke glucose dị n'ọbara. Ndị ọrịa bụ ndị, n'ihi ọnụnọ ọgwụ mgbochi ọrịa, chọrọ insulin insulin dị ukwuu, a na-atụ aro ịnyefe ọgwụ ahụ n'ụlọ ọgwụ n'okpuru nlekọta ahụike dị nso.

Site na njikwa metabolic kachasị mma, mmụba nke mmetụta insulin ga-ekwe omume, n'ihi nsonaazụ nke anụ ahụ maka ya na-ebelata.

Inggbanwe oke nke Insuman Bazal GT nwekwara ike ịdị mkpa ma ọ bụrụ na onye ọrịa ahụ agbanweela ụdị ndụ ya (ọkwa nke mmega ahụ, nri, wdg), ibu ahụ na / ma ọ bụ ọnọdụ ndị ọzọ, n'ihi nke mmụba nke ịkọwapụta na mmepe nke hyper- ma ọ bụ hypoglycemia.

Mkpa insulin nwere ike belata na ndị ọrịa nwere ọrịa akụrụ / ọrịa imeju, na ndị agadi. N'akụkụ a, a ga-eji nlezianya mepụta nhọrọ nke mbido na mmezi ya (iji zere mmepe nke mmeghachi omume hypoglycemic).

  1. Wepu okpu plastik na karama ahụ.
  2. Gwakọta ihe nnochi nke ọma: were vial ya mee ihe na nnukwu akụkụ n'etiti ọbụ aka gị ma jiri nwayọ (zere ịkpụ ụfụfụ) tụgharịa.
  3. Na-anakọta ikuku n'ime sirinji olu nke kwekọrọ na insulin chọrọ, wee banye n'ime vial (ọ bụghị na nkwusioru).
  4. Na ewepụghị sirinji, gbanye karama ahụ ma dọpụta ego kwesịrị ekwesị nke ọgwụ ahụ.
  5. Wepu afụ ikuku si sirinji.
  6. Kpoo akpụkpọ ahụ na mkpịsị aka abụọ, tinye agịga n'ime ntọala ya ma jiri nwayọ gbanye insulin.
  7. Jiri nwayọ, wepụta agịga ahụ ma jiri shịga owu gbanye ebe ntụtụ ahụ ruo ọtụtụ sekọnd.
  8. Dekọọ ụbọchị nke akpa insulin nke mbụ na akara vial.

Ezubere Cartridges iji ya wee jiri pensin ClickStAR na OptiPen Pro1. Tupu itinye ya, ekwesịrị ịchekwa katid ahụ n'ime ụlọ maka 1-2 awa, ebe ọ bụ na inje nke insulin na-agbaze agba na-egbu mgbu. Ikwesiri ịgwakọta nkwusioru ahụ na ọnọdụ ịgakọta: jiri nwayọ gbanye katriki ihe dị ka ugboro 10 (katriiki ọ bụla nwere bọọlụ atọ ga-enye gị ohere ịgwakọta ihe ndị ahụ ngwa ngwa).

Ọ bụrụ na etinyere ihe dị na plọgị n'ime mkpịsị akwụkwọ, gbanye ya na katrij. Ekwesịrị ịme usoro a tupu ochichi ọ bụla nke Insuman Bazal GT.

Emebeghi akwukwo ogbe eji agwunye ogwu na udiri insulin ndi ozo. A gaghị emejupụtabaghị ihe mkpuchi. N'ihe banyere nbibi nke mkpụrụ sirinji, enwere ike ịnye ọgwụ a chọrọ n’aka site na katriiki site na iji sirinji a pụrụ iji kpochapụ nke ọma, na-eji naanị sirinji rọba emepụtara maka insulin a.

Mgbe ịbụnyechara katriki ọhụrụ tupu iwebata ọgwụ nke mbụ, ịkwesịrị ịlele ọrụ ziri ezi nke mkpụrụ sirinji.

Ngwa nke Insuman Bazal GT na pensụl nke SoloStar

Tupu ojiji nke mbụ, a ga-edowe mkpịsị sirinji n ’ụlọ ahụ maka 1-2 awa. N'oge eji ya, enwere ike idobe mkpịsị sirinji na ụlọ okpomọkụ (ruo 25 Celsius C), ma, ọ bụrụ na echekwara ya na friji, ọ ga-ewepụrịrị 1-2 awa tupu ntụtụ.

Tupu ntụtụ ọ bụla, ịkwesịrị ịgwakọta nkwusioru ahụ na otu ịha: jigide mkpịsị ọrịị na mkpịsị nke dị n'agbata ọbụ aka, jiri nwayọ gbanwee ya n'akụkụ ya.

A ga-ewepụrịrị mkpumkpu eji emechi sịrịsh SoloStar ka emegaghị emeju. Iji zere ibute ọrịa, ọ bụ naanị otu onye ọrịa kwesịrị iji mkpịsị ọ bụla sirinji.

Tupu ntụtụ nke mbụ, a na-atụ aro ka ị gụọ ntuziaka maka ojiji nke mkpụrụ edemede SoloStar sirinji - enwere ozi gbasara nhazi dị mma, nhọrọ ọnye na nchịkwa ọgwụ.

Iwu dị mkpa maka iji SoloStar Syringe Pen:

  • jiri naanị agị dakọtara na SoloStar,
  • jiri agịga ọhụụ maka ntụtụ ọ bụla ma mee nnwale nchekwa oge niile,
  • lezie anya iji gbochie ihe ọghọm ndị metụtara agịga na ohere nke ibunye ọrịa,
  • Ejila mkpụrụ sirinji nke mebiri ma ọ bụ usoro ịtụ ọgwụ ọgwụ ahụ kwụsị,
  • kpuchido mkpịsị ọrịre site na unyi na uzuzu (site na mpụga, enwere ike iji akwa dị ọcha ma hichaa ya, ma ị nweghị ike ịsacha, lubricate ma na-emikpu n'ime mmiri, n'ihi na ọ nwere ike imebi),
  • were mkpịsị odee ma ọ bụ nke mbibi ma ọ bụrụ na mbibi ma ọ bụ ọnwụ nke isi.

Ngwa nke mkpụrụ sirinji SoloStar:

Nsonaazụ ndị enwere ike (nkewa dị ka ndị a: ọtụtụ mgbe - ≥ 1/10, ọtụtụ mgbe - site ≥ 1/100 ruo

Ihe eji eme ihe: 1 ml nke nkwusioru nwere 100 ME (3.571 g) nke insulin mmadu. Ndị pụrụ iche: protamine sulfate, m-cresol, phenol, zinc chloride, sodium dihydrogen phosphate dihydrate (E339), glycerol 85% (E422), sodium hydroxide (E524), hydrochloric acid (E507), hydrochloric acid (E507), mmiri hydrobloric acid.

Insuman Bazal GT nwere insulin yiri nke ahuru na insulin mmadu ma nweta site na inyocha ihe omumu site na iji K12 strain E. Coli.

- belata glucose ọbara ma kwalite mmetụta anabolic, ma belata uto catabolic,

- na - akwalite mbufe nke glucose na sel, yana ịkpụkọta glycogen na akwara na imeju na - eme ka ojiji nke pyruvate rụọ ọrụ. Ọ na-egbochi glycogenolysis na glyconeogenesis,

- na-akwalite lipogenesis na imeju na anụ ahụ na-adịrị adị ma na-egbochi lipolysis,

- na - akpali ike amino asịd site na mkpụrụ ndụ ma na - eme ka protein nwee ike,

- na - akwalite oriri nke potassium site na sel.

Insuman Bazal GT (nkwụchi nke isofan-insulin) bụ insulin nwere mmụba nwayọ na ogologo. Mmetụta hypoglycemic dị n'ime elekere 1, wee rute ihe kachasị n'ime awa 3-4 mgbe nchịkwa ọgwụ subcutaneous. Mmetụta ahụ dịgidere ruo 11-20 awa.

Ọkara ọkara nke insul insulin na-achịkwa ahụike dị ihe dịka nkeji isii na isii. Na nnukwu nsogbu gbasara akụrụ, ọ dị ogologo. Okwesiri iburu n'uche na ọgwụ ọgwụ nke insulin anaghị egosipụta mmetụta metabolic ya.

Nsonaazụ Nchekwa Ọsịsịsịsịfọ

Emere ihe omimi banyere ihe ojoo oke mgbe emere ochichi oke. O nweghi ihe ojoo choputara. Ihe omumu banyere ogwu nke aru nke ihe ochichi nke subcutaneous nke ogwu ahu rue oke bekee na nkita kpughere mmeghachi omume hypoglycemic.

Ọrịa shuga mellitus chọrọ ọgwụgwọ insulin.

Ejikọtara mmụọ na-arụ ọrụ ma ọ bụ nke ọ bụla n'ime ndị mebiri emebi.

Enweghi ike inyocha insuman Bazal GT na intraven ma jiri ya na mgbaputa ihe ma obu n'ime insulin nke mpụga.

Onweghi ihe omumu nke ulo ogwu banyere ojiji insulin n’aru mmadu n’oge di ime. Insulin anaghị agafe ihe mgbochi placental. Mgbe ị na-edenye ndị inyom dị ime ọgwụ ahụ, ha kwesịrị ịkpachara anya.

N'ihe banyere ndị ọrịa na-arịa preexisting ma ọ bụ gellational diabetes mellitus, ọ dị mkpa ịnwe ọnụego metabolic kwesịrị ekwesị n'oge afọ ime. Mkpa insulin n'oge ọnwa atọ nke mbụ nke afọ ime nwere ike belata, mana na nke abụọ na nke atọ ọ na - abawanye. Ozugbo amụrụ nwa, ọgwụ insulin na-agbadata ngwa ngwa (ohere dị ukwuu nke hypoglycemia). Ọ dị mkpa iji nlezianya nyochaa ọkwa nke glucose ọbara.

N'oge ị na-enye nwa ara, enweghị mgbochi ọ bụla na usoro insulin. Agbanyeghị, enwere ike ịchọ ọgwụ insulin na ịmegharị ihe nri.

Nhọrọ nke ọkwa glucose ọbara dị mma, nkwadebe insulin na usoro ya maka onye ọrịa ahụ bụ nke dọkịta na-ebu n’otu n’otu, dabere na nri, ọkwa nke mmega ahụ na etu o si ebi ndụ. A na-ekpebi ogo insulin na-adabere n'ọkwa glucose dị n'ọbara, yana dabere na ọkwa nke mmega ahụ na steeti carbohydrate metabolism. Ọgwụ insulin chọrọ ọzụzụ onwe onye dị mma. Dọkịta ga-enye ndụmọdụ dị mkpa ugboro ole iji chọpụta ọkwa nke glucose dị n'ọbara, yana nye nkwenye kwesịrị ekwesị ma ọ bụrụ na mgbanwe ọ bụla na nri ma ọ bụ usoro ọgwụgwọ insulin.

Usoro onunu ogwu ubochi na oge ochichi

Dịka ọ dị, nkezi insulin kwa ụbọchị na-eme ihe sitere na 0,5 ruo 1.0 ME kwa kilogram nke ahụ onye ọrịa, yana ogo 40-60% nke insulin na-arụ ọrụ mmadụ ogologo oge. A na-enyekarị insuman Bazal GT nri nkeji 24-60 tupu nri.

Nghazi udiri ọgwụ na-esote

Improkwalite njikwa glycemic nwere ike ibute mmụba nke insulin, na-eduga n'ịbelata insulin chọrọ. Na mgbakwunye, enwere ike ịchọ ndozi dose, dịka ọmụmaatụ, mgbe ị na-agbanwe oke ahụ onye ọrịa,

- mgbe ịgbanwe ndụ onye ọrịa (gụnyere nri, ọkwa nke mmega ahụ, wdg),

- n’ọnọdụ ndị ọzọ nwere ike ịbawanyewanye ike ịmalite hypoglycemia ma ọ bụ hyperglycemia (lee ntuziaka pụrụ iche na ịkpachara anya maka ojiji).

Ngwa dị iche iche nke ndị chebere iche

N'ime ndị ọrịa agadi na ndị ọrịa nwere obere mkpo ya na ịba ọcha n'anya, enwere ike belata ọgwụ insulin.

A na-achịkwa Insuman Bazal GT na subcutaneously. Nlekọta ọgwụ nchịkwa nke ọbara!

Ntinye insulin na, yabụ, nsonaazụ glucose nke usoro nchịkwa nwere ike ịdị iche dabere na ebe a na-agba agba (dịka ọmụmaatụ, mpaghara nke mgbidi akụkụ ihu ma e jiri ya tụnyere mpaghara feminin).Site na ntụtụ ọ bụla, ekwesịrị ịgbanwe saịtị ntụtụ ahụ n'otu mpaghara ahụ.

Ekwesịrị ịgbanwe saịtị ntụtụ ahụ oge ọ bụla. Shouldgbanwe mpaghara ntụtụ (dịka ọmụmaatụ, site na afọ ruo na apata ụkwụ) ga-eme naanị mgbe ịgachara dọkịta.

A naghị eji insuman Bazal GT n'ọtụtụ ụdị nfuli insulin (gụnyere ndị etinye n'ime ya).

Ejikọla Insuman Bazal GT na insulin nke itinye uche dị iche (dịka ọmụmaatụ, 40 IU / ml na 100 IU / ml), yana insulin nke sitere anụmanụ ma ọ bụ ọgwụ ndị ọzọ.

Ekwesịrị icheta na itinye uche insulin bụ 100 IU / ml (maka vials 5 ml ma ọ bụ katrized 3 ml), yabụ, ọ dị mkpa iji naanị sirinji plastik ezubere maka ịta insulin n'oge a iji mkpịsị vials, ma ọ bụ mkpịsị opipe nke OptiPen Pro1 n'ihe banyere cartridges. Ọkpụkpụ plastik ekwesịghị ịnwe ọgwụ ọ bụla ọzọ ma ọ bụ nha ya.

Tupu izipu insulin nke mbụ na vial ahụ, wepu okpu plastik (ọnụnọ nke okpu bụ ihe akaebe nke vial a na-emechisighi). Nsonye ahụ kwesịrị ka agwakọta nke ọma ozugbo ịmalite ịtọlite ​​ya, ụfụfụ agaghị etolite. A na-eme nke a nke ọma site na ịbugharị kalama ahụ, jigide ya n'otu nnukwu oghere n'etiti ọbụ aka. Mgbe agwakọtara, nkwusioru kwesịrị inwe otu edo edo na ụcha na-acha ọcha. Enweghị ike iji nkwụchi ahụ ma ọ bụrụ na enwere ụdị ọzọ, i.e. ọ bụrụ na ọ na-agbanwe ma ọ bụ flakes ma ọ bụ lumps guzobere na mmiri mmiri onwe ya, na ala ma ọ bụ mgbidi nke vial. N'ụdị ndị ahụ, ịkwesịrị iji karama ọzọ na-emezu ọnọdụ ndị a dị n'elu, ịkwesịrị ịgwa dọkịta gị.

Tupu ịnakọta insulin na vial ahụ, olu ikuku nke kwekọrọ na insulin nke a chọrọ ka a na-arara ga-abanye na sirinji ma gbanye ya n'ime vial (ọ bụghị n'ime mmiri mmiri). A ga-atụzi vial na sirinji jiri sirinji kpoo ma jiri insulin achọrọ ya. Tupu ntụtụ, wepụ afụ ikuku n'ime sirinji.

A na-ewere otu akpụkpọ ebe a na-agba ntụtụ, na-etinye agịga n'okpuru anụ ahụ, a na-ejikwa insulin nwayọọ nwayọọ. Mgbe agwesịrị, a na-eji nwayọ wepụrụ agịga ahụ ma jiri ajị owu na-agbanye ya ruo ọtụtụ sekọnd. E kwesịrị idekọ ụbọchị nke akpa insulin site na vial ahụ na akara nke vial ahụ.

Mgbe emepechara, ị nwere ike ịchekwa karama ndị ahụ n ’ọnọdụ okpomọkụ na-agaghị akarị +25 Celsius C maka izu anọ n’ebe a na-echebe ọkụ na ikpo ọkụ.

Tupu ị wụnye kadi ahụ (100 IU / ml) na mkpịsị mkpụrụ ogwu OptiPen Pro1, hapụ ya ka ọ kwụrụ 1-2 ruo mgbe ọ dị n'ọnụ ụlọ. Mgbe nke a gasiri, jiri nwayọ gbanye katriiki (ugboro iri) iji nweta nkwụghachi nke otu. Ihe mgbakwasa obula nwere ihe ozo di iche n’ime ato maka ijiko ihe di n’ime ha. Mgbe ịbatasịrị katalọgụ n’ime mkpịsị sirinji, pịchaa mkpịsị sirinji ọtụtụ oge tupu ntụtụ insulin ọ bụla iji nweta nkwụchi otu. Mgbe agwakọtara, nkwusioru kwesịrị inwe otu edo edo na ụcha na-acha ọcha. Enweghị ike iji nkwụchi ahụ ma ọ bụrụ na enwere ụdị ọzọ, i.e. ọ bụrụ na ọ na-agbanwe ma ọ bụ flakes ma ọ bụ lumps guzobere na mmiri mmiri onwe ya, na ala ma ọ bụ mgbidi nke katrij. N'ụdị ndị ahụ, ịkwesịrị iji katriiki ọzọ na-emezu ọnọdụ ndị a dị n'elu, ịkwesịrị ịgwa dọkịta gị. Wepu uzu ikuku ọ bụla na kateeti tupu ntụtụ (lee ntuziaka maka iji OptiPen Pro1 Syringe Pen).

Emebeghi kaadi ihe ahu ighe Insuman Bazal GT na insulins ndi ozo. Enweghi ike imejuputa katrized ụgbọ ala.

N'ihe banyere nbibi nke mkpụrụ sirinji, ị nwere ike tinye mkpụrụ a chọrọ iji si na katalọgụ jiri sirinji ot. Ekwesịrị icheta na itinye uche nke insulin na katriiki bụ 100 IU / ml, yabụ naanị ịchọrọ iji sirinji plastik ezubere maka itinye insulin nke ntinye.Sirinji ahụ ekwesịghị ịnwe ọgwụ ọ bụla ọzọ.

Mgbe itinyechara katriji ahụ, enwere ike iji ya - ® maka> izu anọ. Ọ na-atụ aro ịchekwa ya n'ọnọdụ okpomọkụ nke na-agaghị akarị 25 Celsius C n’ebe a na-echebe ya site n’ọkụ na ọkụ. Mgbe ị na-eji kọọdụ, ekwesịghị ịchekwa mkpụrụ sirinji na friji.

Mgbe ịbụnyechara katriki ọhụrụ, lelee ọrụ ziri ezi nke mkpịsị ọrịrị tupu ị banye ntụtụ ọgwụ mbụ (lee Ntuziaka maka iji sirinji OptiPen Pro1).

Ọrịa hypoglycemia, nke kachasị emetụta ya, nwere ike ịmalite ma ọ bụrụ na insulin insulin na-akwado gafere mkpa ọ dị. Ọ gaghị ekwe omume igosipụta kpọmkwem ọnọdụ nke hypoglycemia, ebe ọ bụ na uru a na nnwale ụlọ ọgwụ yana iji ọgwụ azụmaahịa nwere ike ịdị iche dabere na ọnụ ọgụgụ ndị mmadụ na usoro ọgwụgwọ. Ọnọdụ siri ike nke hypoglycemia, karịsịa ma ọ bụrụ na a na-eme ya ugboro ugboro, nwere ike ibute mmepe nke mgbaàmà akwara, gụnyere coma, cramps. N'ọnọdụ ụfọdụ, ụdị nke a nwere ike ịnwụ.

N'ọtụtụ ndị ọrịa, akara nke hypoglycemic mbibi nke usoro akwara na-ebute ụzọ site na akara nke adrenergic counterregulation. Dịka iwu, ka ịbawanye n'ọkwa nke glucose n'ọbara na-ebelata, ka a na-akpọkwu ya bụ ihe ịtụnanya na njikwa na akara ya.

Mmeghachi omume ndị a na-esote iji ọgwụ ahụ ma hụkwaa ule dị iche iche edepụtara site na klaasị akwara sistemu na nbelata usoro omume: ihe a na-ahụkarị (> 1/100, 1 / 1.000, 1/10000 ,


  1. Boris, Moroz und Elena Khromova Ọrịa ịwa ahụ na ezughi oke na ndị ọrịa nwere ọrịa mellitus / Boris Moroz und Elena Khromova. - M .: LAP Lambert Publishing, 2012 .-- 140 p.

  2. Dreval, A.V. Mgbochi nke oke oke macrovascular nsogbu nke ọrịa shuga mellitus / A.V. Dreval, I.V. Misnikova, Yu.A. Kovaleva. - M.: GEOTAR-Media, 2013 .-- 716 p.

  3. Evsyukova I.I., Kosheleva N.G. Ọrịa shuga mellitus. Ime na ụmụ amụrụ ọhụrụ, Miklos -, 2009. - 272 c.
  4. Nri na-agwọ ọrịa shuga. - M.: Clublọ ezumike nke ezumike ezinụlọ, 2011. - 608 c.
  5. Zakharov Yu.L. Ọgwụ ndị India. Ezi ntụziaka. Mbipụta Mbipụta Moscow, Pressverk, peeji nke 2001,475, puku ise

Ka m kọwaa onwe m. Aha m bụ Elena. Anọwo m na-arụ ọrụ dị ka ọkà mmụta endocrinologist ruo ihe karịrị afọ 10. Ekwenyere m na abụ m ọkachamara n'ọhịa m ugbu a, m chọrọ inyere ndị ọbịa niile nọ na saịtị ahụ aka idozi ihe dị mgbagwoju anya ọ bụghị ọrụ. A na-achịkọta ihe niile dị na saịtị ahụ ma jiri nlezianya hazie iji kọọ ozi niile dị mkpa. Tupu itinye ihe akọwara na weebụsaịtị, ndụmọdụ mmetụtara na ndị ọkachamara dị mkpa mgbe niile.

Mmeghachi omume ọjọọ

Hypoglycemia, mmetụta kachasị na-esokarị, nwere ike ịmalite ma ọ bụrụ na ọgwụ insulin na-achịkwa karịa ọ dị mkpa (lee "ịkpachara anya na ntuziaka pụrụ iche").
Nnukwu mgbanwe n’ọbara shuga nwere ike ibute ọgba aghara n’oge. Ọzọkwa, ọkachasị mgbe a na - eji insulin ọgwụ ike, ọ ga - ekwe omume, obere oge ọ na - akawanye njọ nke ọrịa mamị retinopathy enwere. N'ime ndị ọrịa nwere ọrịa retinopathy na-abawanye uru, na-enweghị iji usoro ọgwụgwọ laser, ọnọdụ hypoglycemic siri ike nwere ike ibute ìsì.
Mgbe ụfọdụ atrophy ma ọ bụ hypertrophy nke adipose anụ ahụ nwere ike ime na saịtị ịgba ntụtụ, nke a ga-ezere site na ịgbanwe saịtị injection mgbe niile. N'ọnọdụ ndị na-adịghị ahụkebe, obere ncha ọbara ọbara nwere ike ịmalite na saịtị ịgba ahụ, na-apụ n'anya site na iji usoro ọgwụgwọ. Ọ bụrụ na etisoro erythema dị mkpa, ya na itching na ọria, na ngwa ngwa gbasaa ebe a na-agbanye ya, yana mmeghachi omume ndị ọzọ dị njọ na mmiri ọgwụ (insulin, protamine, m-cresol, phenol), ị kwesịrị ịgwa dọkịta ahụ ozugbo, yabụ dị ka ụfọdụ, mmeghachi omume ndị dị otú ahụ nwere ike ibute ndụ onye ọrịa. Nnukwu mmetọ a na-ahụ anya na-adịkarị obere. Ha nwekwara ike ibute site na mmepe nke ọrịa angioedema, bronchospasm, mbelata ọbara mgbali elu na ujo anacticlactic adịkarịsịrị ike.Ihe mmeghachi omume hypers na-achọ mgbazi ozugbo na ọgwụgwọ na-aga n'ihu na insulin na ntinye nke usoro ihe mberede kwesịrị ekwesị.
Ikekwe iguzogide ọgwụ mgbochi nye insulin, nke nwere ike ịchọ mgbanwe nke insulin na-achịkwa. Ọ ga - ekwe omume, njigide sodium na - esochi anụ ahụ n'ụba, ọkachasị mgbe ọgwụgwọ insulin gbasiri ike.
Site na mbelata nke ọma na ọkwa shuga dị n'ọbara, ọ ga-ekwe omume ịmalite hypokalemia (nsogbu site na sistem ụbụrụ) ma ọ bụ mmepe nke ụbụrụ.
Ebe ụfọdụ mmetụta ụfọdụ nwere ike, n'ọnọdụ ụfọdụ, na-eyi ndụ egwu, ọ dị mkpa ịgwa ndị dibịa bekee mgbe ha mere.
Ọ bụrụ n ’ụnwee mmetụta ọ bụla, biko kpọtụrụ dọkịta gị!

Ime na lactation

Ọgwụgwọ Insuman ® Basal GT n'oge afọ ime ga-aga n'ihu. Insulin anaghị agafe ihe mgbochi placental. Maintenancenwe ọgwụ mgbochi ọrịa n'ụzọ dị mma n'oge afọ ime bụ ihe dịịrị ndị inyom nwere ọrịa shuga tupu ime ime, ma ọ bụ maka ndị inyom nweela ọrịa shuga.

Mkpa insulin n'oge ime nwere ike ibelata n’oge ọnwa atọ mbụ dị n’afọ nke afọ ime, ọ na-agbadakarị n’oge ọnwa nke abụọ na nke atọ. Ozugbo amụrụ nwa, ọgwụ insulin na-agbada ngwa ngwa (ohere dị ukwuu nke hypoglycemia). N’ime afọ ime, ọkachasị mgbe amụchara nwa, a chọrọ iji nlezianya leba anya n’obara glucose na ọbara.

Ọ bụrụ na ị dị ime ma ọ bụ na-eme atụmatụ ịtụrụ ime, jide n’aka gwa dọkịta gị.

N'oge a na-enye nwa ara, enweghị mgbochi ọ bụla na usoro ọgwụgwọ insulin, agbanyeghị, enwere ike ịchọrọ insulin ọgwụ na ịmegharị nri.

Nsonaazụ

Hypoglycemia. Mmetụta mmetụta insulin na-enwekarị nwere ike ịmalite ma ọ bụrụ na ọgwụ insulin na-eduzi karịrị mkpa ọ dị (lee “Ntuziaka Pụrụ Iche”). Ọnọdụ siri ike ugboro ugboro nke hypoglycemia nwere ike ibute mmepe nke mgbaàmà akwara, gụnyere coma, cramps (lee “doụbiga ya ókè”). Ogologo oge ma ọ bụ nnukwu nsogbu nke hypoglycemia nwere ike ịnwe ndụ.

N'ọtụtụ ndị ọrịa, mgbaàmà na ngosipụta nke neuroglycopenia nwere ike ibute akara nke mgbanwe mgbanwe (na nzaghachi na ịmalite hypoglycemia) nke sistemụ ọmịiko ọmịiko. Ọtụtụ mgbe, iji nkwupụta dị mkpịsị ma ọ bụ belata ngwa ngwa n'ọbara glucose n'ọbara, ihe nrịba ama nke ịgbanyụ sistemụ ọmịiko na ihe mgbaàmà ya na-ekwupụta karịa.

Site na mbelata nke ukwuu na glucose n'ọbara, mmepe nke hypokalemia (nsogbu site na CCC) ma ọ bụ mmepe nke ọrịa ụbụrụ ga-ekwe omume.

Ihe ndi a bu ihe ojoo ndi huru na nnwale nke ulo ogwu nke ndi mmadu n’agha site n’usoro ahu ma n’usoro n’ibelata nke ukwu: ugboro ugboro (≥1 / 10), ugboro ugboro (≥1 / 100 na obara mgbali (onaghi amaghi)) na ujo anacticlactic. mmeghachi omume nkwụghachi azụ nwere ike itinye ndụ mmadụ n'ihe ize ndụ .. Mmeghachi omume nfụkasị chọrọ ihe ngwa ngwa ozugbo ọ bụla .. use useụ insulin nwere ike ime ka nguzobe ọgwụ mgbochi insulin (ugboro ugboro amabeghị). Sulin nwere ike ịchọ mgbanwe nke insulin iji mezie ebumnuche nke hyper - ma ọ bụ hypoglycemia.

Site n'akụkụ nke metabolism na nri: insulin nwere ike ime ka njigide sodium (ugboro ugboro amaghi) na edema (oge ụfọdụ), ọkachasị mgbe ị na-emeziwanye usoro metabolic na-ezughị ezu site na iji insulin ọgwụ na-agbasi ike.

Site n'akụkụ akụkụ ahụ nke ọhụụ: mgbanwe dị ukwuu na njikwa glycemic nwere ike ịkpata ọgba aghara nke anya (oge amabeghị) n'ihi mgbanwe nwa oge na turgor nke oghere anya na ntụgharị ntụgharị.

Ọganiite ogologo oge na njikwa glycemic na-ebelata ohere ịbawanye ọrịa mamịrị retinopathy mamịrị. Agbanyeghị, usoro ọgwụgwọ insulin siri ike na mmụba dị ukwuu na njikwa glycemic nwere ike jikọta nbibi nwa oge na-arịa ọrịa ọrịa retinopathy (ugboro ugboro amaghị). N'ime ndị ọrịa nwere ọrịa retinopathy na-abawanye uru, ọkachasị ma ọ bụrụ na ha anaghị anata ọgwụgwọ na photocoagulation (usoro ọgwụgwọ laser), nnukwu ịba ụba hypoglycemic nwere ike ibute trensient amaurosis (ọnwụ nke ọhụụ zuru oke) (ugboro ole na-amaghị).

Na akpụkpọ anụ ahụ dị ka ọ dị na ọgwụ insulin ọ bụla, ọ ga-ekwe omume ịzụlite lipodystrophy n’ebe a na-agba ya mmiri (a na-amaghị ugboro ole) na ibelata insulin mpaghara.

Sitesgbanwe saịtị ntụtụ oge niile na mpaghara nchịkwa akwadoro nwere ike inye aka belata ma ọ bụ ịkwụsị mmeghachi ndị a.

Ọrịa na nkwarụ izugbe na saịtị ịgba ahụ: mmeghachi omume dị nro na-ebukarị na ebe ahụ. Ndị a gụnyere ịcha ọbara ọbara n’ebe a na-agbanye ya (ugboro ole na-amaghị), mgbu n’ebe a na-agba mịpụta (ugboro ole na-amaghị), itching na ntụtụ ọnọdụ (amaghi ugboro), urticaria n’ebe ngbanye (amaghi ugboro), ọzịza na mpaghara ịgba ntụtụ (amaghi ugboro) ma ọ bụ mmeghachi omume mkpali. n’ebe a na-agba ntụtụ (a na-amaghị ugboro ole).

Mmeghachi omume kachasị na insulin na saịtị ịgba ahụ na-apụ n'anya mgbe ụbọchị ole na ole ma ọ bụ izu gasịrị.

Ntụziaka pụrụ iche

N'ọnọdụ nchịkwa glycemic ezughị ezu ma ọ bụ echiche nke akụkụ nke hyper- ma ọ bụ hypoglycemia, tupu ị kpebie ịgbanwe insulin, jide n'aka na ị ga-elele usoro insulin na-achịkwa, jide n'aka na a na-abanye insulin n'ime mpaghara ahụ a tụrụ aro, lelee izizi nke usoro ịgba ọgwụ na ihe ndị ọzọ niile. nke ahụ nwere ike imetụta nsonaazụ insulin. N'ihi na n'otu oge iji ọtụtụ ọgwụ (lee “Mmekọrịta”) nwere ike iweda ma ọ bụ welie mmetụta hypoglycemic nke ọgwụ Insuman ® Basal GT, site na iji ya ị nweghị ike ị takeụ ọgwụ ọ bụla na-enweghị ikikere pụrụ iche site na dọkịta.

Hypoglycemia. Ọ na - eme ma ọ bụrụ na ọgwụ insulin na - akarị mkpa maka ya. Ihe ọghọm nke ịrịa hypoglycemia dị elu na mmalite nke ọgwụgwọ insulin, mgbe ị na-agbanye na nhazi insulin ọzọ, na ndị ọrịa na-enwe oke ntinye glucose n'ọbara.

Dị ka ọ dị na insulins niile, a ga-elebara anya pụrụ iche ma nyochaa nlebara anya nke glucose ọbara n'ọbara maka ndị ọrịa hypoglycemic nke nwere ike ịnwe ọfụma pụrụ iche, dị ka ndị ọrịa nwere nnukwu stenosis nke akwara ọbara ma ọ bụ akwara akwara (ihe egwu nke akwara obi ma ọ bụ nsogbu nke hypoglycemia), ka akwadoro. , yana ndị ọrịa nwere ọrịa retinopathy na-abawanye uru, ọkachasị ma ọ bụrụ na ha enwetabeghị fotocoagulation (ọgwụgwọ laser), ha nwere ihe ize ndụ nke nhụjuanya oge (kpuru ìsì zuru oke) na mmepe nke hypoglycemia.

Enwere ụfọdụ mgbaama na akara aka nke kwesịrị igosi onye ọrịa ma ọ bụ ndị ọzọ gbasara ịmalite hypoglycemia. Ndị a gụnyere: ọsụsọ gabigara ókè, mmiri dị n’akpụkpọ ahụ, tachycardia, obi ọgbụgba, obi mgbali, mgbali obi, mgbu, ụjọ, agụụ, iro ụra, ọgba aghara ihi ụra, ụjọ, ịda mba, ahụ mgbakasị ahụ, omume pụrụ iche, nchekasị, paresthesia n'oge ọnụ na gburugburu ọnụ, pallor nke anụ ahụ, isi ọwụwa, nkwonkwo nkwonkwo akwara, yana nkwarụ akwara na-adị n’ofe (na-ekwu okwu n’abụ ọhụụ, na-arịa mkpọnwụ) na mmetụta pụrụ iche. Site n'ibelata mgbanye glucose, onye ọrịa nwere ike ịkwụsị njide onwe onye na ọbụna nsụhọ. N'ụdị ndị dị otú ahụ, enwere ike ịmịchaa ma ọ bụ iru mmiri nke akpụkpọ ahụ, ihe ọdịdọ nwekwara ike ịpụta.Ya mere, onye ọrịa ọ bụla na - arịa ọrịa shuga nke na - enweta insulin kwesịrị ịmụta mgbaàmà ndị a na - adịghị ahụkebe nke na - egosi ịmalite hypoglycemia. Ndị ọrịa na-enyocha mkpokọta glucose n'ọbara, o yikarịrị ka ịmalite ịmalite hypoglycemia. Onye ọrịa ahụ n’onwe ya nwere ike idozi mbelata mgbanye glucose ọbara ọ chọpụtara site n’ịri shuga ma ọ bụ nri dị oke carbohydrates. Maka ebumnuche a, onye ọrịa ahụ kwesịrị ịnwe glucose 20 g mgbe niile.

Na ọnọdụ siri ike karị nke hypoglycemia, a na-egosipụta ntụtụ glucagon (nke dọkịta ma ọ bụ ndị ọrụ nọọsụ nwere ike ịme ya). Mgbe mmezi zuru oke, onye ọrịa ahụ kwesịrị iri nri. Ọ bụrụ na enweghị ike iwepụ hypoglycemia ozugbo, mgbe ahụ, ekwesịrị ịkpọ dọkịta ozugbo. Ọ dị mkpa ịgwa dọkịta ozugbo maka mmepe nke hypoglycemia ka o wee mee mkpebi banyere mkpa ịhazigharị ọgwụ insulin. Ọ bụrụ na ịgbaso usoro nri, ịpụ insulin insulin, ịba ụba insulin n'ihi ọrịa na-efe efe ma ọ bụ ọrịa ndị ọzọ, na mbelata ọrụ mmega ahụ nwere ike ibute mmụba nke glucose ọbara (hyperglycemia), ikekwe site na mmụba nke mkpo ahụ nke ketone na ọbara (ketoacidosis). Ketoacidosis nwere ike itolite n’ime awa ole na ole ma ọ bụ ụbọchị ole na ole. Na mgbaàmà mbụ nke metabolic acidosis (akpịrị ịkpọ nkụ, urination ugboro ugboro, ụkọ nri, ike ọgwụgwụ, anụ ahụ akpọnwụ, iku ume na ngwa ngwa, oke acetone na glucose na mmamịrị), itinye ọgwụ ngwa ngwa dị mkpa.

Mgbe ị na-agbanwe dọkịta (dịka ọmụmaatụ, n’oge ụlọ ọgwụ n’ihi ihe ọghọm, ọrịa n’oge ezumike), onye ọrịa ahụ ga-agwa dọkịta na o nwere ọrịa shuga.

E kwesiri ịdọ ndị ọrịa aka na ntị gbasara ọnọdụ ha nwere ike ịgbanwe, belata ya ma ọ bụ nwee enweghị mgbaàmà ịdọ aka ná ntị banyere mmepe nke hypoglycemia, dịka ọmụmaatụ:

- na-enwe ezigbo ọganihu na njikwa glycemic.

- mmalite nke hypoglycemia,

- n'ime ndị ọrịa agadi,

- n'ime ndị ọrịa nwere ọrịa kansa akwara,

- n'ime ndị ọrịa nwere ogologo ọrịa shuga,

- n'ime ndị ọrịa n'otu oge na-anata ọgwụgwọ na ọgwụ ụfọdụ (lee "Mmekọrịta"). Ọnọdụ ndị dị otú a nwere ike iduga mmepe nke hypoglycemia siri ike (yana enwere ike na enweghị uche) tupu onye ọrịa achọpụta na ọ na-etolite hypoglycemia.

Ọ bụrụ na achọpụtara na haemoglobin dịkarịsịrị njọ ma ọ bụ belata ahụ, enwere ike ịtụle ọrịa hypoglycemia ugboro ugboro, nke a na-akọwaghị (ọkachasị n'ehihie).

Iji belata ihe ize ndụ nke hypoglycemia, onye ọrịa ahụ ga-agbasochi usoro ọgwụ edenye ya na usoro nri, na-achịkwa injections insulin nke ọma ma dọọ ya aka ná ntị banyere ihe mgbaàmà nke ịmalite ịmalite hypoglycemia.

Ihe ndị na - eme ka ịbawanye ụba nke mmepe hypoglycemia chọrọ nlezianya nlebara anya ma nwee ike ịchọ mmezi dose. Ihe ndị a gụnyere:

- mgbanwe na mpaghara nchịkwa nke insulin,

- mụbara insulin na-abawanye (dịka ọmụmaatụ, iwepụ ihe ndị na - akpata nrụgide),

- arụ ọrụ na - adịghị ahụkebe (ụba ma ọ bụ ogologo oge),

- oria abuo (interromrent pathology) (vomiting, afọ ọsịsa),

- nri ezughi ezu,

- nri,

- ụfọdụ ọrịa endocrine na - agbanweghi agbanwe (dịka hypothyroidism na nkwonkwo ezughi oke ma ọ bụ ezughi oke ibu).

- imekotaotu aka nke ufodu ogwu (lee. “Nmekorita”).

Ọrịa. N'ime ọrịa ndị a na - eme mgbochi, achọrọ akara metabolic kpụ ọkụ n'ọnụ. N'ọtụtụ oge, a na-egosi nnwale mmamịrị maka ọnụnọ nke ozu ketone, na nhazi nke insulin na-adịkarị mkpa. Mkpa insulin na-abawanye.Ndị ọrịa nwere ụdị shuga nke 1 kwesịrị ịnọgide na-a atụ obere obere carbohydrates oge niile, ọbụlagodi na ha nwere ike were ntakịrị nri ma ọ bụ ọ bụrụ na ha nwere ọfụma na ha agaghị akwụsị ị takingụ insulin kpamkpam.

Mmeghari ahụ mgbochi mgbochi. N'ime ọnụ ọgụgụ dị ukwuu nke ndị ọrịa nwere insulin na-emetụta insulin nke anụmanụ, ọ na-esiri ike ịgbanwere insulin nke mmadụ n'ihi mmeghachi omume mgbochi insulin nke insulin mmadụ na insulin nke sitere anụmanụ.

Site na mmụba dị ukwuu nke onye ọrịa ka insulin sitere na anụmanụ, yana m-cresol, ekwesịrị ịnagide ịnagide ọgwụ Insuman ® Basal GT n'ụlọ ọgwụ iji nyocha intradermal. Ọ bụrụ na nnwale intradermal gosipụtara insulin na-enyocha insulin mmadụ (mmeghachi omume ozugbo, dị ka Arthus), mgbe ahụ, a ga-eme ọgwụgwọ ọzọ n'okpuru nlekọta ahụike.

Mmetụta ikike ịkwọ ụgbọala ma ọ bụ usoro ndị ọzọ. Ike nke onye ọrịa itinye uche na ọsọ nke psychomotor mmeghachi omume nwere ike imebi n'ihi hypoglycemia ma ọ bụ hyperglycemia, yana nsonaazụ ọgba. Nke a nwere ike ibute otu nsogbu n'ọnọdụ ikike ndị a dị mkpa (ịnya ụgbọ ma ọ bụ usoro ndị ọzọ).

Ekwesịrị ịgwa ndị ọrịa ka ha kpachara anya ma zere hypoglycemia mgbe ha na-anya ụgbọala. Nke a dị oke mkpa na ndị ọrịa belatara ma ọ bụ amaghị banyere mgbaàmà ndị na-egosi mmepe nke hypoglycemia, ma ọ bụ nwee nsogbu nke hypoglycemia ugboro ugboro. N'ime ndị ọrịa dị otu a, a ga-ekpebi ajụjụ gbasara ikwe ike iji ụgbọ ala ma ọ bụ usoro ndị ọzọ were ha.

Emeputa

Sanofi-Aventis Deutschland GmbH, Germany. Industrialpark Hoechst D-65926, Bruningstrasse 50, Frankfurt, Germany.

Ekwesịrị izipu ndị na-azụ ahịa na adreesị na Russia: 125009, Moscow, ul. Tverskaya, 22.

Tẹ.: (495) 721-14-00, faksị: (495) 721-14-11.

N'ihe banyere imepụta ọgwụ ahụ na Sanofi-Aventis Vostok CJSC, Russia, a ga-ezigara mkpesa ndị ahịa na adres ndị a: 302516, Russia, Oryol Region, Oryol District, s / n Bolshekulikovskoye, ul. Livenskaya, 1.

Tel./fax: +7 (486) 2-44-00-55.

Ihe na-egosi na contraindications: enwere ike ọ na-akpata nsonaazụ

Ihe ngosi maka iji aru oru insulin Bazal bu udiri 1 na udiri oria abuo, mgbe achoro ngwakọta nke onodu hypoglycemic onu na insulin.

A na-egbochi ọgwụ ahụ n'ọnọdụ nfụkasị ahụ na otu n'ime ihe dị na anamnesis. Enyekwala homonụ ahụ n’arịa ọrịa hypoglycemia.

Ọ bụrụ na ọnọdụ ndị a dị n'okpuru, a ga-eji insuman Bazal GT jiri nlezianya na nlezianya na-ahụ maka nlekọta ahụike:

  • N’ime ndị okenye.
  • N’enweghi akụrụ na umeji ọrụ.
  • N'ime ndị ọrịa nwere stenosis nke akwara akwara.
  • Achọpụtara ọgwụ retinopathy proliferative, ọkachasị site na photocoagulation.
  • Ọrịa ọgbụgba na ntanetị nke na-eme ka insulin na-abawanye.

A na - egbochi ndị ọrịa n'oge hypoglycemia

Ọnọdụ ndị a chọrọ nlekọta nke dọkịta nke ga-ekpebi ma insulin mkpụmkpụ ma ọ bụ ogologo ga-adabara otu onye ọrịa yana otu esi ejikọta nlekọta ha.

Agaghị akwụsị ọgwụgwọ nke ọrịa shuga na ụmụ nwanyị dị ime. Insuman Bazal GT anaghị agafe na Plasenta, nke pụtara na ọ naghị emetụta nwata ahụ. Ọ bụrụ na ọrịa shuga bidoro n’oge afọ ime (mmeme), ọ dị mkpa ịhazi ọkwa shuga n’oge dum nke mmegharị ahụ. N’ime oge izizi, mkpa iji insulin rụ ọrụ nwere ike belata, n’ime oge abụọ na atọ ọ nwere ike ịba ụba. Mgbe amuchara nwa, a ghala n’ihu na choro homonu. N'ime inye ụmụ ara, enweghị ọgwụ mgbochi ọ bụla maka ịhọpụta Insuman Bazal.

Mmeghachi omume ọjọọ nwere ike ime mgbe ị na-eji insulin dị ukwuu ma ọ bụ mebie nchịkwa ya. Ọgwụ insulin ọ bụla nwere ike ịdị mgbagwoju anya site na steeti hypoglycemia. Mgbagha a na - apụta na ọnọdụ ebe enwere njikwa ahụ karịrị mkpa anụ ahụ. A na-ahụ nke a na ndị okenye, mgbe ha na-ahapụ nri, mana inulin, arụ ọrụ siri ike, ị alcoholụ mmanya, n'abalị. Dabere na mgbaàmà ụlọ ọgwụ, ọ ga-edo anya na ọkwa shuga agbadala nke ukwuu:

  • Ọsụsọ na-apụta.
  • Mmetụta agụụ.
  • Iri ura nke akwara ohuru na nsogbu ura.
  • Ọrịa ịda mba.
  • Mgbaàmà nke akwara ozi (paresthesia, isi ọwụwa, nsogbu na nhazi nke mmegharị, mgbanwe n'okwu na ọhụụ, syndromes paralytic).

Ọrụ nke akụkụ obi ọmịiko nke sistem akwara autonomic na-eduga na nnukwu palpitations, ọsụsọ, mkpụmkpụ ume, arrhythmias, ihe mgbu na amụma nke obi, ọbara mgbali elu.

Usoro ahụ ji alụso ọrịa ọgụ nwere ike ịzaghachi na nchịkwa Insuman Bazal GT nwere mmeghachi ahụ nfụkasị ozigbo, bronchospasm, angioedema, na ujo anacticlactic adịkarịghị mma.

N'ime ndị ọrịa nwere mmụba na insulin anụmanụ, o siri ike ịgbanwe gaa na nkwadebe mmadụ nwetara site na injinịa mkpụrụ ndụ ihe nketa. Mgbe ahụ, a na-eme nnwale intradermal nke na-enyere aka ịchọpụta mmeghachi omume hypersensitivity.

Insulin nwere ike ibute njigide sodium n’ime ọbara, yabụ enwere ike itolite edema n’oge ọgwụgwọ.

Ọ bụrụ na ịgbanweghị ọgwụ injections insulin, mgbe ahụ ha na-etolite dystrophy nke abụba subcutaneous yana nnabata nke ọgwụ na-ebelata. Ọzọkwa, mgbu, ịcha ọbara-ọbara, mmeghachi omume dịka hives, itching and swelling may muuq in banga injection. Dị ka ọ na-adịkarị, mgbe ụbọchị ole na ole gasịrị, mmeghachi omume ndị dị otú a na-agafe.

N'ime ndị agadi, mkpa insulin dị ala, nke pụtara na a na-eji nlezianya ahọrọ usoro onunu ogwu ka ọ ghara ibute hypoglycemia.

Ofzọ nchịkwa na usoro ọgwụgwọ

Ntụziaka maka ojiji Insuman Bazal GT na-enye nhọrọ nke usoro onunu ogwu, dabere n'ọnọdụ onye ọrịa yana mkpa ọ nwere homonụ. A na-agbakọ ọ̀tụ̀tụ̀ shuga dị n’ọbara, imega ahụ́, steeti metabolism nke carbohydrates.

Ná nkezi, a chọrọ 0-1-1.0 insuman Bazal GT kwa ụbọchị na nkezi kwa 1 n'arọ nke ịdị arọ nke onye ọrịa ahụ. Ejikọtara ya na insulin na-arụ ọrụ ogologo oge, ọkacha mma site na otu onye na-emepụta ihe. Usoro ọgwụgwọ usoro onunu ogwu ga-eme n’okwu ndị a:

  • Ntugharị sitere na insulin anụmanụ.
  • Ntughari insulin nke megasiri ike nkpuru ogwu nye mmadu.
  • Dochie onye insulin na-arịa ọrịa mmadụ nwere ogologo ọrụ.
  • Dịkwuo ma ọ bụ ibelata ịdị arọ onye ọrịa na mmega ahụ.
  • Ọnọdụ ebe enwere ike ịmalite hyper - ma ọ bụ hypoglycemia.

Usoro ọgwụgwọ a na-eme ndị agadi na-agbazi. N'ime ndị agadi, achọrọ insulin dị ala, yabụ ahọpụtara usoro ọgwụgwọ ma dozie ya nke ọma ka ị ghara ibute ọrịa hypoglycemia. N'ime ndị ọrịa nwere ọrịa imeju na akụrụ nke gaferela oke oke ọrụ, achọrọ mbelata usoro onunu ogwu.

Bazal GT na ngwugwu nwere vials ogwu di na milion 5. Ọ dịkwa na katridges 3 ml. Maka igba ogwu, nkeji iri- ise-60 tupu i rie nri, a na-anakọta ego achọrọ maka mmachi ahụ na sirinji insulin. Tinye subcutaneously n'ime n'oghere dị na afọ, hips. Site na oge ịgba ọgwụ oge ka agbanwere ma gbanye ya na dọkịta. Ego a nabatachara n’ime ọbara na mmepe nke nsonaazụ a bụ ihe amachibidoro ime ihe ndị a:

  • Webata ọgwụ n’agha.
  • Jiri ya na mmiri insulin.
  • Gwakọta n’otu ntụtụ na ụdị insulin ndị ọzọ, gụnyere ụmụ anụmanụ si malite, na itinye uche n’ihe iche.

Tupu ị mejupụta ihe nrịba n'ime sirinji ahụ, ịkwesịrị ịgbanye karama ahụ ma jiri ya mee ka ọ bụrụ nkwụchi. O kwesịghị ịfụfụ ma nwee ụcha dị iche na nke egosipụtara na ntuziaka ahụ.Ọ bụrụ na mgbe ịghachara flakes na lumps guzobere na iko ahụ, mgbe ahụ enweghị ike iji ọgwụ dị otú ahụ.

Mgbe ojiji mbụ, enwere ike ịchekwa karama ahụ maka izu 4 na okpomọkụ na-enweghị ogo 25, na-echebe site na ìhè. Ka ị ghara ichefu, egosipụtara ụbọchị mmeghe na mpempe akwụkwọ. A naghị atụ aro itinye karama na-emeghe na friji: injections nwere insulin oyi na-akpata mgbu dị ukwuu.

Analogs na ọnụ ahịa

Ọnụahịa nke Insuman Bazal, dabere na olu nke karama, sitere na 268 ruo 1695 rubles. Ọnụ ego ahụ dị iche na mpaghara Russia na ụlọ ọgwụ dị n'ịntanetị.

Rinsulin NPH (ọnụ ahịa site na 420 rubles), Biosulin (site na 500 rubles), Ọnọdụ Mberede Insulin Ọnọdụ (310 rubles), Rosinsulin (site na 1000 rubles) nwere ike ịghọ analogues nke Insuman Bazal.

Onye dochie anya ọgwụ ahụ nwere ike ịhọrọ dọkịta ziri ezi. Ya mere, n'ihe gbasara insulin ọgwụgwọ maka ọrịa shuga mellitus, ị selfụ ọgwụ onwe ya dị ize ndụ.

Nọmba ndebanye : P Nke 011994/01 nke July 26, 2004

1 ml nke mwepu na-anọpụ iche maka ntụtụ nwere 100 IU nke insulin mmadụ (100% crystalline insulin protamine).
Ndị pụrụ iche: protamine sulfate, m-cresol, phenol, zinc chloride, sodium dihydrogen phosphate dihydrate, glycerol, sodium hydroxide, hydrochloric acid, mmiri maka injection.

Ntọhapụ mwepụta, ụgwọ ọnụ

A na - enweta insulin basal dị ka mkpọchi nke subcutaneous na usoro onunu ogwu nke 100 IU / ml. Ofdị izipu mbụ bụ karama nke iko ma ọ bụ iko enweghị agba. A na-eji stopa emechi akụkụ elu nke karama ahụ, nke a na-etinye okpu aluminom. Maka mkpuchi siri ike, a na-etinye okpu plastik n'isi okpu ahụ. Ike nke karama a bu 5 ml. Na shelves nke ụlọ ahịa ọgwụ, enwere ike ịhụ insulin Bazal na ngwugwu nke ampoules 5 nwere ntuziaka maka ojiji.

Ofdị mgbapụta ọzọ bụ katrized nke iko doro anya nke nwere 3 ml. Ejiri stopa kpuchie elu nke katriki ahụ, a na-etinye okpu aluminom n’elu ya. Akụkụ dị ala na-ejikwa onye na-akụ ọkpọ. Na mgbakwunye, enwere bọọlụ atọ dị na katriiki. Otu ngwugwu ọ bụla nwere katrized 5. Ha chọkwara pen-syringe.

Thirddị mgbapụta nke atọ bụ katrized dị na pensụl dinSSS disposable disposer. A na-eme ha iko doro anya na ike nke 3 ml. Na mpụga, katriiki ahụ dị ka ọ dị na mbụ. N'elu akwa mmiri jiri okpu alumini dị n’elu. Akụkụ dị ala nke katịl ahụ na-ejikwa onye na-akụ ọkpọ. Kọọlụ ọ bụla nwere bọọlụ atọ. N'okwu a, ngwugwu ahụ nwere pensụ pensụ 5 na ntuziaka maka ojiji.

Onu ogugu ego nke ogwu a di ihe dika 1000 rubles. Ọnụ ego ahụ dabere n'ụdị mgbapụta ahọrọ.

General njirimara. Ngwakọta:

Ihe na - arụ ọrụ: insulin mmadụ (100% crystalline insulin protamine) - 3.571 mg (100 IU),
ndị na - ahụkarị: protamine sulfate - 0.318 mg, metacresol (m-cresol) - 1,500 mg, phenol - 0,600 mg, zinc chloride - 0,047 mg, sodium dihydrogen phosphate dihydrate - 2,100 mg, glycerol (85%) - 18,824 mg, sodium hydroxide (ejiri ya iji dozie pH) - 0.576 mg, hydrochloric acid (nke a na-eji dozie pH) - 0.246 mg, mmiri maka injection - ruo 1.0 ml.
Nkọwa: nkwụsị nke agba ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ụcha, na-adị mfe ịgbasa.

Ngwá ọgwụ ọgwụ:

Mlọ ọgwụ Insuman® Basal GT nwere insulin ahaziri ahaziri ya na insulin nke mmadu ma nweta site na inyocha mkpụrụ ndụ ihe nketa site na iji E. coli K12 strain 135 pINT90d. Usoro nke insulin na-arụ:
- na - eme ka ịbawanye ụba nke glucose n'ọbara, na - akwalite mmetụta anabolic ma belata mmetụta catabolic,
- na-abawanye nyefe nke glucose n'ime sel yana guzobe glycogen na akwara na umeji ma na - eme ka ojiji nke pyruvate, gbochie glycogenolysis na glyconeogenesis,
- na-abawanye lipogenesis na imeju na anụ ahụ na-adị ọcha ma na-egbochi lipolysis,
- na - akwalite nha nke amino acids n’ime sel na protein protein,
- na - abawanye uru nke potassium n’ime sel.
Insuman® Basal GT bụ insulin na-arụ ọrụ ogologo oge nke nwere usoro nwayọ nwayọ. Mgbe nchịkwa subcutaneous gasịrị, mmetụta hypoglycemic na-apụta n'ime elekere 1, wee rute kachasị n'ime awa 3-4. Mmetụta ahụ dịgidere ruo 11-20 awa.

Mlọ ọgwụ N'ime ahụike, ọkara ndụ nke plasma insulin dị ihe dị ka nkeji isii na isii. N'ime ndị ọrịa nwere nnukwu nsogbu gbasara akụrụ, ọ dị ogologo. Agbanyeghị, ekwesịrị ịmara na ọgwụ ọgwụ nke insulin anaghị egosipụta mmetụta metabolic ya.

Imeghari uzo ozo

Site na njikwa metabolic kachasị mma, mmụba nke mmetụta insulin ga-ekwe omume, n'ihi nsonaazụ nke anụ ahụ maka ya na-ebelata.

Inggbanwe oke nke Insuman Bazal GT nwekwara ike ịdị mkpa ma ọ bụrụ na onye ọrịa ahụ agbanweela ụdị ndụ ya (ọkwa nke mmega ahụ, nri, wdg), ibu ahụ na / ma ọ bụ ọnọdụ ndị ọzọ, n'ihi nke mmụba nke ịkọwapụta na mmepe nke hyper- ma ọ bụ hypoglycemia.

Mkpa insulin nwere ike belata na ndị ọrịa nwere ọrịa akụrụ / ọrịa imeju, na ndị agadi. N'akụkụ a, a ga-eji nlezianya mepụta nhọrọ nke mbido na mmezi ya (iji zere mmepe nke mmeghachi omume hypoglycemic).

Ngwa Insuman Bazal GT na karama

  1. Wepu okpu plastik na karama ahụ.
  2. Gwakọta ihe nnochi nke ọma: were vial ya mee ihe na nnukwu akụkụ n'etiti ọbụ aka gị ma jiri nwayọ (zere ịkpụ ụfụfụ) tụgharịa.
  3. Na-anakọta ikuku n'ime sirinji olu nke kwekọrọ na insulin chọrọ, wee banye n'ime vial (ọ bụghị na nkwusioru).
  4. Na ewepụghị sirinji, gbanye karama ahụ ma dọpụta ego kwesịrị ekwesị nke ọgwụ ahụ.
  5. Wepu afụ ikuku si sirinji.
  6. Kpoo akpụkpọ ahụ na mkpịsị aka abụọ, tinye agịga n'ime ntọala ya ma jiri nwayọ gbanye insulin.
  7. Jiri nwayọ, wepụta agịga ahụ ma jiri shịga owu gbanye ebe ntụtụ ahụ ruo ọtụtụ sekọnd.
  8. Dekọọ ụbọchị nke akpa insulin nke mbụ na akara vial.

Ngwa Insuman Bazal GT na katrized

Ezubere Cartridges iji ya wee jiri pensin ClickStAR na OptiPen Pro1. Tupu itinye ya, ekwesịrị ịchekwa katid ahụ n'ime ụlọ maka 1-2 awa, ebe ọ bụ na inje nke insulin na-agbaze agba na-egbu mgbu. Ikwesiri ịgwakọta nkwusioru ahụ na ọnọdụ ịgakọta: jiri nwayọ gbanye katriki ihe dị ka ugboro 10 (katriiki ọ bụla nwere bọọlụ atọ ga-enye gị ohere ịgwakọta ihe ndị ahụ ngwa ngwa).

Ọ bụrụ na etinyere ihe dị na plọgị n'ime mkpịsị akwụkwọ, gbanye ya na katrij. Ekwesịrị ịme usoro a tupu ochichi ọ bụla nke Insuman Bazal GT.

Emebeghi akwukwo ogbe eji agwunye ogwu na udiri insulin ndi ozo. A gaghị emejupụtabaghị ihe mkpuchi. N'ihe banyere nbibi nke mkpụrụ sirinji, enwere ike ịnye ọgwụ a chọrọ n’aka site na katriiki site na iji sirinji a pụrụ iji kpochapụ nke ọma, na-eji naanị sirinji rọba emepụtara maka insulin a.

Mgbe ịbụnyechara katriki ọhụrụ tupu iwebata ọgwụ nke mbụ, ịkwesịrị ịlele ọrụ ziri ezi nke mkpụrụ sirinji.

Ọnọdụ ezumike:

Nkwụsịtụ maka nchịkwa okpuru ala nke 100 IU / ml.
5 ml nke ọgwụ na karama nke transperent na iko enweghị agba (ụdị nke m). Akpọchie karama ahụ, were okpu alịumịnọn kpuchie ya ma kpuchie ya na mkpuchi okpu. 5 vials nwere ntuziaka maka iji ya na igbe kaadiboodu.
3 ml nke ọgwụ na katriiki nke iko na-enweghị ọ (ụ na enweghị agba (ụdị nke m). A na-adọkpụ katrij ahụ n'otu akụkụ ya na cork ma jiri okpu aluminom wee mie ya, n'aka nke ọzọ - ya na eriri. Ọzọkwa, a na-etinye bọọlụ ọla atọ n'ime katalọgụ. 5 katalọgụ n’otu mpịakọta mkpọ nke ihe nkiri PVC na ihe mkpuchi nke aluminom.Nkwakọ ngwaahịa 1 blister tinyere ntuziaka maka iji ya na igbe kaadiboodu.
3 ml nke ọgwụ na katriiki nke iko na-enweghị ọ (ụ na enweghị agba (ụdị nke m). A na-adọkpụ katrij ahụ n'otu akụkụ ya na cork ma jiri okpu aluminom wee mie ya, n'aka nke ọzọ - ya na eriri. Ọzọkwa, a na-etinye bọọlụ ọla atọ n'ime katalọgụ. A na-etinye bọọdụ ahụ na penSSS® disposable syringe pen. On 5 SoloStar® pensụl pensụl na Ntụziaka itinye n'ọrụ na kaadiboodu.

N'etiti ọtụtụ insul mmadụ, a na-eji ọgwụ pụrụ iche eme ihe ogologo oge. Isi ihe dị na ya bụ ojiji ọrụ ya ọgwụgwọ nke ụdị shuga 1 na ụdị shuga 2 ọrịa shuga. Onye mepụtara ọgwụ ahụ bụ Sanofi-Aventis.

Insulin Insuman Bazal nwere ike ịbụ ezigbo onye inyeaka n’ịkwarị ọrịa shuga kwụ chịm (na-emegidekwa hyperglycemia na-adịchaghị ala ma nwee ọ̀tụ̀tụ̀ shuga dị n’ọbara dị ala). A na-eji ya maka ọgwụ insulin kpụ ọkụ n'ọnụ na oge gboo na ụtụtụ abụọ (ụtụtụ na mgbede) nke homonụsị nwapụtara nke arụ ogologo.

Ebumnuche ebumnuche ọgwụ ahụ bụ ị simomi nzuzo basal eke, nke pancreas na-arụpụta ụbọchị niile. Omume nke ọgwụ ahụ na-amalite na awa 1-5.5 mgbe nchịkwa n'okpuru anụ ahụ, dịruru site na awa 11 ruo 20. Ọnụ ọgụgụ kachasị elu na-adabata n'etiti oge awa 4-6 site na mmalite nke nchịkwa. Ogologo oge nke ọrụ na-adabere na usoro eji ahọpụta ahịrị nke saịtị ịgba ahụ, njirimara nke ahụ. Ọtụtụ mgbe, tupu nri ụtụtụ, a na-eji ọgwụ ahụ eme ihe nkeji iri anọ na ise ruo iri ise na ise tupu nri.

Iji nweta nkwụghachi zuru oke, ọ bụ ihe amamihe dị na mbụ ịhọrọ usoro onunu ogwu n'ụlọ ọgwụ pụrụ iche na-eburu profaịlụ glycemic kwa ụbọchị. Mgbe ị na-ebufe onye ọrịa site na insulin insulin na mmadụ, ọtụtụ oge, mbelata usoro a na-emebu. Ọ bara uru ịbịaru nso maka nhọrọ nke ọgwụ maka obere yana ndị ọrịa chọrọ ntakịrị enyemaka site na homonụ nke mpụga iji zere ndị siri ike.

Insuman Bazal gt kwesịrị ekwesị naanị maka nchịkwa subcutaneous. Ekwenyere na iji ya nwere ike weghachi mkpụrụ ndụ na homonụ nke ya, yabụ, na-arịa ụdị shuga 2, ọgwụ insulin edepụtara na-abụkarị nwa oge.

Iji jikwaa ọgwụ subcutaneously, ị nwere ike iji sirinji nkịtị ma ọ bụ mkpịsị ọgbara ọhụrụ . Iji ihe eji eme ihe nwere ike ime ka inje kwa ụbọchị dịkwuo mfe, mee ka ndụ onye ọrịa dịkwuo mma. Ọdịdị nke ngwaọrụ na kọmpat akụkụ na-atọkwa ụtọ.

You nwere ike gwakọta ọgwụ a na ọgwụ Sanofi-Aventis ndị ọzọ ma ọ bụrụ na itinye uche ha bụ otu (dịka 100 na 40 nkeji / ml enweghị ike ịgwakọta kpamkpam!). Agbanyeghị, ekwenyeghị ya ka ejikọta ọgwụ ahụ na insulins anụmanụ, ọgwụ ndị ezubere maka ọgwụgwọ mgbapụta na analogues na otu karama.

Cheta: mgbe agwakọta n’ime sirinji, homonụ nke na-adị mkpụmkpụ bụ oge mbụ ọ ga-abụ mkpụrụ akwụkwọ!

Insuman Rapid

A na - eji insulin injinia nke mmadụ na - arụ ọrụ na - agwọ ọrịa shuga. Na-atụgharị uche na ọgwụ ndị na-adịghị adịte aka. Ọ na-amalite ịrụ ọrụ mgbe nkeji iri ise gasịrị, ọ na-apụta dịka o kwere mee na etiti awa 1-4, ọ na-adịgide ruo elekere 7. Ugwu a na-akpọ akpọ ga-enyere gị aka ịhazi ibu nke carbohydrate ogologo oge, na-edozi usoro iri nri dị ka profaịlụ ọgwụ si dị.

A na-eji ọgwụ insulin gbanye ya n'okpuru akpụkpọ ahụ. Enwekwara pensụ pensụl pịnyere Solostar. Enwere ike ibibi ngwaọrụ ndị nwere ike ịtụfu mgbe njedebe katrij.

O zuru oke maka nkwụghachi ụgwọ na ndị okenye nwere ike ịgbaso usoro a na-eme kwa ụbọchị ma na-eme atụmatụ mmega ahụ zuru oke. A na-eji ya dị ka ọgwụ ọgwụ buru ibu na ụmụaka nwere obere insulin. Ọ nwere mmetụta dị mma na nguzobe nke ụlọ ahịa glycogen na imeju na akwara.

Mmetụta dị n'akụkụ bụ hypoglycemia siri ike. Ọ na - abụkarị mgbe usoro ọgwụgwọ enweghị ihe agafee oke. Mmeghachi omume Allergic na - eme mgbe ụfọdụ n'ụdị urticaria, edema mpaghara, na itching. Kwesịrị ekwesị maka ojiji nke mbadamba ọgwụ shuga dị ala na nkwado nke dọkịta gị.

Ejiri nke oma maka ọgwụgwọ. Achọghị ịkwụsị ya mgbe a na-enye ya ara. Dos nwere ike ịdị iche iche dabere na mkpa anụ ahụ.

Vial emepere nke Insuman Rapid ma ọ bụ Insuman Bazal gt na-adịgide ruo ụbọchị 28. A na-echekwa ya n'ime ụlọ ahụ, a naghị anabata ya. Kalama ọhụrụ ahụ kwesịrị ịdị na ọnọdụ okpomọkụ + 2 + 8 agaghị akarị afọ abụọ. Mgbe ọ gwụsịrị, ojiji ahụ nwere ike ibute ahụike.

Chetakwa, enwere ike iji usoro ọgwụgwọ ọ bụla maka ọrịa endocrine mgbe naanị gị na dọkịta gị gachara! Medication medicationụ ọgwụ onwe gị nwere ike ịdị njọ.

Ahapụ Gị Ikwu